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RESUMO 
COMPLICAÇÕES ASSOCIADAS À COLOCAÇÃO DE BYPASS URETERAL 
SUBCUTÂNEO (SUB) EM GATOS: ESTUDO RETROSPETIVO  
A obstrução ureteral é uma patologia cada vez mais frequente, especialmente em gatos, sendo 
a causa mais comum uma obstrução intraluminal secundária a ureterolitíase. O diagnóstico e 
maneio médio da obstrução ureteral deve ser feito de forma célere uma vez que pode induzir 
um rápido declínio da função renal assim como lesões irreversíveis do parênquima renal. A 
colocação de um Bypass Ureteral Subcutâneo (SUB) tem sido uma operação terapêutica 
crescente, constituindo um novo tratamento paliativo promissor. 
Este estudo pretende descrever as potenciais complicações e prognóstico de gatos com 
diagnóstico de obstrução ureteral e submetidos à colocação de um dispositivo SUB num centro 
de referência da região parisiense, assim como detetar fatores que possam ter influenciado estes 
parâmetros. Foi efetuado um estudo retrospetivo com uma análise detalhada dos dados clínicos 
de 129 gatos nos quais foi colocado um SUB num centro de referência na área Parisiense.  
As complicações graves identificadas consistiram em oclusão (n=41, 32%), mineralização do 
dispositivo (n=10, 8%) e extravasamento de urina do dispositivo ou do trato urinário (n=6, 5%). 
As complicações ligeiras descritas foram: sinais de disúria (n=38, 29%), bacteriúria (n=32, 
25%) e anemia (n=25, 19%). 
A nível temporal, as complicações graves foram identificadas em média 541 dias após a cirurgia 
e foram associadas à presença de letargia e oligúrio-anúria aquando da admissão hospitalar. Já 
as complicações ligeiras, estas foram observadas 148 dias após a cirurgia, com uma associação 
a anorexia ou disorexia prévias à hospitalização assim como a um historial de doença renal 
crónica. A realização de uma segunda ou mais cirurgias foi associado tanto com complicações 
graves como ligeiras. 
A taxa de mortalidade do presente estudo foi de 19% mas esta não se correlacionou com 
complicações ou com qualquer outro parâmetro testado, sugerindo assim que, o prognóstico de 
após intervenção continua incerto.  
Em suma, os resultados do presente estudo sugerem que a colocação de um dispositivo SUB é 
um tratamento viável de obstrução ureteral em gatos, com reduzidas complicações a curto e 
longo prazo, quando comparado com os stents ureterais e cirurgias ureterais tradicionais. 
Apesar da dificuldade em identificar fatores de prognóstico, os resultados deste estudo 
demonstram que, gatos com obstruções ureterais podem ter um bom prognóstico após a 
colocação de um dispositivo SUB.  
Palavras-chave: Obstrução Ureteral, Ureterolitíase, Gato, Bypass Ureteral Subcutâneo, 
Complicações 
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ABSTRACT 
COMPLICATIONS ASSOCIATED TO SUBCUTANEOUS URETERAL BYPASS 
(SUB) PLACEMENT IN CATS: A RETROSPECTIVE STUDY 
 
The ureteral obstruction is becoming more frequent pathology, especially in cats, with the most 
common cause being an intraluminal obstruction secondary to ureterolithiasis. The diagnosis 
and medical management of ureteral obstruction should be made early as it may induce a rapid 
decline in renal function and irreversible lesions on the renal parenchyma. The placement of a 
Subcutaneous Ureteral Bypass (SUB) has been an increasing therapeutic option, considered as 
promising palliative treatment. 
This study aimed to identify potential complications and outcome of cats with a diagnosis of 
ureteral obstruction and submitted to the placement of a SUB device in one referral center in 
the Paris area, as to detect factors that may had an influence in these parameters. A retrospective 
study was performed with a detailed analysis of the medical records of 129 cats submitted to 
the placement of a SUB device in one referral center in the Paris area. 
The major complications identified consisted in occlusion (n=41, 32%), mineralization of the 
device (n=10, 8%) and urine leakage from the device or urinary tract (n=6, 5%). The minor 
complications described were: dysuria (n=38, 29%), bacteriuria (n=32, 25%) and anemia 
(n=25, 19%).  
Major complications were seen a mean of 541 days after the surgery and were associated with 
the presence of lethargy and oligo-anuria at hospital admission. In the other hand, minor 
complications were observed 148 days after the surgery and were associated with anorexia or 
dysorexia at the hospital admission and a history of chronic kidney disease. The need for a 
second or more surgeries was significantly associated with both minor and major complications. 
The overall mortality rate of the present study was 19% but this was not associated with 
complications or other parameters tested, suggesting that, the prognosis after the intervention 
remains uncertain.  
In summary, results of the present study suggest that the placement of a SUB is a viable 
treatment of ureteral obstruction in cats, with fewer short and long-term complications when 
compared with ureteral stents and traditional ureteral surgery. Despite the difficulty to identify 
prognostic factors, the results of this study demonstrate that, cats with ureteral obstruction could 
have a good prognosis after a SUB device placement. 
 
Key words: Ureteral obstruction, Ureterolithiasis, Cat, Subcutaneous Ureteral Bypass, 
Complications  
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1. DESCRIPTION OF THE TRAINEESHIP ACTIVITIES 
The trainee completed two traineeships. The first externship was in the Centre Hospitalier 
Vétérinaire Frégis (CHV-Frégis), in Arcueil-France and the second was at the Centre 
Hospitalier Universitaire Vétérinaire d'Alfort (ChuvA), situated in Maison Alfort-France.  
The curricular externship was performed in the CHV-Frégis, under the supervision of Dr. Julie 
Lemétayer (Dipl. ACVIM). It lasted from 1/10/18 until 28/01/19, with a total duration of 
4 months, reflecting approximately 756 hours.  
The externship at the ChuvA was a 2 month-long extracurricular externship, which began 
on the 4/02/19 and lasted until 5/04/19, in a total of 385 hours, under the supervision of Dr. 
Celine Robert. Overall, the externship lasted 6 months, counting a total of 1141 hours of 
practical activities.   
 
Traineeship at the CHV-Frégis 
The first 2 months in the CHV-Frégis were spent in the Internal Medicine service and the last 
2 months in the Surgery department.  In both services two daily medical rounds happened, one 
as the day started and the other at the final of the day. Before those rounds, general examination 
to each hospitalized animal was performed by the trainee and the intern. In these rounds, all 
hospitalized animals were presented by the responsible clinician and an elaboration of a 
differential diagnosis list as well as complementary exams, surgeries and treatments were 
discussed. These medical rounds were attended by the day-time and night-time intern, senior 
clinicians, residents, board-certified specialists, nurses and trainees. 
In the Internal Medicine service, both the trainee the intern conducted complementary exams 
and some treatments. The activities performed included: biochemical and urinary analysis, 
collection of blood samples, measurement of blood pressure, packet cell volume, 
electrocardiograms performance and reading, insertion of vascular and urinary catheters, 
nasoesophageal feeding tubes, collection of urine through cystocentesis and blood type 
typification. Besides that, the trainee assisted in the positioning of patients for 
ultrasonographical examination, both abdominal and cardiac, management of fluid therapy, 
drug administration and blood transfusions. The trainee had the opportunity to work in 
emergency cases and assist cardiopulmonary resuscitation (CPR). Occasionally, the trainee had 
the chance to assist to interventions such as gastrointestinal endoscopies, rhinoscopies, 
transtracheal/bronchoalveolar washes, bronchoscopies, enemas and thoracocentesis.  
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In the surgery service, the trainee and the intern aided the head nurse in the administration of 
pre-medications, complementary exams, management of fluid therapy and bandages and wound 
management. Afterwards, the trainee helped in the preparation of animals for surgery namely 
by preparing the anesthesia and pre-medication, administering the drugs, intubating the patient, 
doing the asepsis of the surgical field and transferring the animal into the surgical table. In all 
surgeries, the position of second hand surgeon was held by the trainee in alternation with the 
intern. Therefore, the trainee was able to participate in multiple soft tissue surgeries and the 
most frequent were: laparoscopic ovariectomies, brachycephalic surgery and palatoplasty with 
a CO2 laser, removal of intestinal foreign bodies, cystotomy procedures, hepatic lobectomies, 
mastectomy, placement of a SUB device, gastric volvulus, diaphragmatic and perineal hernias. 
Other more unusual surgeries assisted were: cesarean sections (and respective neonatal 
reanimation), correction of patent ductus arteriosus, thoracotomies, thoracoscopies, 
pericardectomies, ligation of portosystemic shunts, repair of the hard palate cleft, total ear canal 
ablation, unilateral arytenoid cartilage lateralization, correction of chylothorax and ectopic 
ureters. 
The trainee also assisted in orthopedic and neurologic surgeries such as total hip replacements, 
tibial plateau leveling osteotomies, trochleoplasties, tibial tuberosity transpositions, 
arthroscopies, laminectomies, corpectomies and fracture corrections. The short-term 
postoperative care was mainly conducted by the trainee and the intern, under supervision of a 
senior clinician. Once again, if there was free time between surgeries, the trainee could go and 
attend consultations, which helped her to understand the entire path that leads to a surgery and 
to further discuss it with the senior clinician.    
In both services, most of the days had moments of debate and discussion, in which the author 
and senior clinicians would discuss a multitude of cases. The trainee could also go and attend 
consultations with high graduated clinicians, which was an opportunity to debate differential 
diagnoses, diagnostic and treatment plans, as well as to develop critical thinking skills. 
Every Friday morning, the trainee went and assisted to continuous practice education given by 
senior clinicians. These lectures were integrated in the hospital routine in order to support a 
continuous formation of their clinicians with the most recent advances in veterinary medicine.  
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Traineeship at the ChuvA 
The externship at the ChuvA was based on weekly rotations, and the services attended were: 
Dermatology, Preventive Medicine, Reproduction, Surgery, Convenience Surgery, Internal 
Medicine, Ophthalmology, Neurology, Cardiology, Exotic Animals, Physiotherapy and 
Rehabilitation. 
The trainee individually received each animal and did an initial pre-consultation. The pre-
consultation started by taking the medical history, performing a general clinical examination 
and, when needed, an orthopedic or neurologic exam along with basic laboratory testing. 
Afterwards, the trainee presented the case to the responsible clinician, with a list of differential 
diagnoses and proposing justified complementary exams, in order to reach the definitive 
diagnose, as well as an appropriate treatment plan. Following the consultation, it was 
responsibility of the trainee to ensure that all complementary exams and procedures were 
performed and to write the clinical report. At the end of the day, the team discussed clinical 
cases and some topics were further debated in small lectures given by senior clinicians.  
The first week was carried out in the service of Preventive Medicine, where the trainee learnt 
about some of the legislation and vaccination plans of the country. The trainee had the 
responsibility of choosing the most suitable plan to the animal, fill in passports, introducing the 
electronic identification and prescribe accurate anti-parasitic treatment.  
In the second week, in the service of Reproduction, the trainee had the chance to assist to 
artificial inseminations, collection of semen samples, gestational echographies and monitoring 
reproductive cycles. 
Afterwards, in the service of Internal Medicine, the trainee was exposed to several cases, which 
were amply discussed with clinicians. In the pre-consultation, the trainee was responsible to 
guide and accompany the animal when there was the need of hospitalizations, radiographic or 
echographic exams. 
In Ophthalmology, it was requested to the trainee to perform fundoscopic exams, Schirmer 
tests, fluorescein tests, reflexes tests, amount other.  
In Cardiology, the trainee assisted to various echocardiographic exams and electrocardiograms, 
had clinical discussions about treatment plans and attended lectures given by board-certified 
specialists.  
Regarding the Neurology department, the trainee had to perform detailed neurologic exams and 
interpret its results to provide a list of differential diagnoses.  
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Concerning the Exotic Animals service, pre-consultations were performed both in small 
mammals and birds. Moreover, the clinicians held lectures about the most common diseases in 
these animals, which were attended by small groups of students.  
In the Surgery service, the trainee did pre-consultations in which she performed orthopedic and 
neurologic exams when needed. Furthermore, she had the opportunity to discuss diagnoses and 
surgical approaches with the responsible clinician. In the Convenience surgery service, the 
trainee had the opportunity to perform sterilizations and castrations of cats as a first hand 
surgeon. The animal was the trainee’s responsibility since the pre-consultation, during the 
anesthetic induction, the surgical procedure until the postoperative management. Moreover, the 
trainee assisted to other surgeries such as cesareans sections (and respective neonatal 
reanimation), total ear canal ablation, pyometras and correction of a vaginal hyperplasia. The 
students also attended sessions of physiotherapy and rehabilitation such as hydrotherapy, 
electric stimulation and massages 
Lastly, the trainee spent her last week in the Dermatology service where she collected skin and 
fur samples which were afterwards analyzed. There was also the opportunity to attend small 
lectures given by board-certified specialists and to participate debates. 
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2. BIBLIOGRAPHIC REVIEW 
2.1 Urinary system anatomy 
The kidneys and ureters are in the retroperitoneal space. The kidneys are paired, bean-shaped 
structures and each of them has a cranial and caudal pole and a ventral and dorsal aspect. The 
right kidney is firmly attached and associated with the renal fossa of the caudate liver lobe. The 
left kidney is generally more mobile and lies more caudally than the right kidney (Lanz & 
Waldron, 2000).  
The hilus is located in the medial aspect, where the renal artery, nerves and lymphatic vessels 
enters and the renal vein and ureter exit (Tobias & Tillson, 2018). Blood supply to the kidneys 
comprise approximately 25% of the cardiac output. It has been reported that 10% of cats have 
multiple renal arteries supplying the kidneys, especially the left kidney. This is particularly 
important when considering nephrotomy or nephrectomy (Christie, 2003). 
The kidney is composed of an outer cortex and an inner medulla. Externally, there is a fibrous 
capsule that is surrounded by adipose tissue, which can make gross evaluation of size difficult, 
especially in obese animals. The urine flows to the renal pelvis through the collecting ducts and 
is evacuated by the ureter (Tobias & Tillson, 2018). 
The ureters are fibromuscular tubes that transport urine from the renal pelvis to the urinary 
bladder. They course caudomedially along the psoas major and minor muscles. The left ureter 
runs laterally to the aorta, while the right ureter is lateral to the caudal vena cava, until both 
ureters turn ventrally to the urinary bladder after passing the extern iliac vessels (Adams, 2017). 
In a small portion of animals, the ureters (more commonly the right ureter) is abnormally 
deviated medially and crosses the caudal vena cava dorsally which results in a retrocaval or 
circumcaval ureter (Cornillie, Baten & Simoens, 2006; Doust, Clarke, Hammond, Paterson & 
King, 2006).  
Between the ureteral openings in the urinary bladder wall and the proximal urethral opening in 
the urinary bladder neck there is a region named the trigone (Lipscomb, 2018). Just before 
entering the urinary bladder in the trigone region, the ureters recurves slightly, resulting in a j-
shaped conformation. Then, they run obliquely within the urinary bladder wall resulting in a 
valve-like effect called the vesicoureteral valve. This promotes a unidirectional flow of urine 
that prevents the reflux of urine to the kidneys (Adams, 2017). 
The length and diameter of ureters vary among species and breeds. The normal diameter of the 
feline ureter’s lumen has been reported to be between 0.3 to 0.4mm. This is a predisposing 
factor for ureteral obstruction (Hardie & Kyles, 2004; Berent, Weisse, Todd & Bagley, 2014). 
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With fluid diuresis these values can increase but normally the maximum ureteral luminal 
diameter is less than 2.7mm (Adams, 2017). 
The ureters are composed of an inner mucosal layer, constituted by a transitional cell epithelium 
and the lamina propria, several layers of smooth muscle and an outer adventitial layer, as seen 
in figure 1. The lumen is normally collapsed and opens only when the bolus of urine passes 
through. In the urinary bladder, the mucosa continues through the wall, but the muscle layer is 
replaced by the attachments of the detrusor muscle (Hardie & Kyles, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The urinary bladder, composed by an apex, a body and a neck, lies within the peritoneal cavity 
and is attached to the abdominal wall by the median ligament and the lateral ligament. The 
median ligament is ventral and can be cut before cystostomy while the lateral ligaments contain 
fat along with the distal portion of the ureter (Lipscomb, 2018).  
The urinary bladder is constituted by an outer serosa, the detrusor muscle and the urothelium, 
with consists of a transitional cell epithelium and the submucosa. The interdigitating fibers of 
the detrusor muscle are continuous with the smooth muscle of the urethra, which means that 
there is no anatomically distinct internal sphincter at the vesicourethral junction (Lipscomb, 
2018). 
2.2 Physiology  
The kidneys have an important role in maintaining the homeostasis. They regulate the volume 
and composition of extracellular fluid by producing urine. They respond to water, electrolyte, 
and acid-base disturbances by specifically altering the rate of reabsorption or secretion of these 
Figure 1. Section of a normal ureter from an adult cat (adapted from Hardie & Kyles, 2004). 
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substances. In addition, they have a number of endocrine function and are integral in the 
regulation of the systemic blood pressure and in the red blood cell production (Valender, 2013). 
The basic functional unit of the kidney is the nephron. The nephron is composed by the renal 
corpuscle, where the blood is filtered forming the ultrafiltrate, and by the renal tubules, where 
some filtered substances are reabsorbed and some plasma components are secreted. The volume 
of ultrafiltrate formed is primarily determined by the functional renal mass but it is also affected 
by the hydrostatic pressure within the glomerular capillary tuft (Valender, 2013). 
Normally, water and solutes are freely filtered while all the cellular components and plasma 
proteins with the size of albumin are retained in the bloodstream. Substances with a molecular 
radius of 4 nm or more are not filtered whereas molecules with a radius of 2 nm or less are 
filtered without restriction. However, the net electrical charge of a molecule also affects his 
filtration’s rate, the cationic form of many substances being more freely filtered than the neutral 
form which is itself more freely filtered than the anionic form of the same molecule (Valender, 
2013). 
The majority of the ultrafiltrate formed in the glomerulus is reabsorbed by the renal tubules 
rather than excreted in the urine. Thus, there is a reabsorption of most filtered water and solutes 
as Na+, Cl- and HCO3-, appearing only in minimal quantities in the urine and a complete 
reabsorption of the glucose and amino acids, that are not normally found in the urine besides at 
high filtered rate (Valender, 2013). 
Substances that need to be eliminated by the urine, as urea and creatinine, are very poorly 
reabsorbed which results in an important excretion. The same occurs to exogenous substances 
and drugs, the reabsorption almost do not exist and furthermore, these substances are actively 
secreted into the tubular fluid, resulting in a high excretion rate (Valender, 2013). 
2.3 Evaluation of the renal function 
Azotemia is defined as a concentration of nitrogenous waste products in the blood above their 
reference intervals, which generally happens when 75% or more of the nephrons become non-
functional. When adverse clinical manifestations are present in a more severe azotemia, the 
term uremia is used, to describe this clinical syndrome (MacPhail & Fossum, 2019). It is 
important to not just look for values outside the references intervals but understand that small 
changes in BUN (blood urea nitrogen) and/or creatinine concentrations may indicate significant 
pathology since those abnormal values are normally seen later in disease, as illustrated in figure 
2 (Palm, 2017).  
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Animals with a renal azotemia have a compromised urine concentration ability, with urine 
specific gravity (USG) values less than 1.035 in cats. Many cats with chronic kidney disease 
(CKD) present USG values between 1.006 and 1.020 and, in advanced stages of CKD, it is 
common to find isosthenuria, with USG values between 1.008 and 1.012. Despite all of this, 
some cats with CKD may preserve a substantial urine concentration ability (Polzin, 2017). 
The glomerular filtration rate (GFR) is a clinically useful measure of the renal function and 
most frequently kidney diseases are diagnosed when GFR decreases with subsequent decrease 
excretion of renal biomarkers, leaving the animal azotemic (Palm, 2017). The determination of 
the GFR is the gold standard for measuring the renal function but due to its complexity and 
costs, other renal biomarkers have been used as an indirect measure of the GFR, even if early 
decreases in the GFR are not recognized by those indicators (Hall, Yerramilli, Obare & Jewell, 
2014). Despite this insensitivity, the most commonly measured biomarkers are BUN and 
creatinine, but they represent only a fraction of the molecules that undergo decreased excretion 
in azotemia (Palm, 2017).  
Urea is a nitrogen-containing compound and BUN is the measure of the amount of nitrogen 
urea in the blood (Palm, 2017). Urea is synthesized in the liver from the amino acids derived 
from the catabolism of exogenous and endogenous proteins. It is freely filtered at the 
glomerulus however, it can be reabsorbed from the renal tubules, and this occurs to a greater 
extent at slow tubular flow rates. Therefore, BUN is not a reliable indicator of 
GFR.  Furthermore, production and excretion of urea is not constant. Serum creatinine is often 
used as a more reliable measure of GFR than BUN in patients with CKD (Ghys et al., 2014).  
Figure 2. Correlation of the serum concentration creatinine and the GFR (adapted from 
Nabity et al., 2015). 
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Furthermore, extrarenal factor may increase the urea concentration such as gastro intestinal 
hemorrhage, clinical conditions which increase catabolism as starvation, infection, fever, and 
some drugs, such as glucocorticoids. A diet with high protein intake can also increase BUN 
concentration, so a 12-hour fast is recommend before measuring BUN concentration. In this 
situation, a concurrent increase in serum creatinine concentration may not occur (DiBartola & 
Westropp, 2014).   
Extra renal factors that can decrease the BUN concentrations are a low protein diet, a 
malabsorption, urea cycle enzyme deficiencies, iatrogenic overhydration and diseases that 
prevents water removal or causes a polyuria and polydipsia, such as hyperadrenocorticism and 
diabetes insipidus (DiBartola & Westropp, 2014; Palm, 2017).  
The measurement of the creatinine serum concentration is generally preferred to the urea, as 
the concentration of the creatinine appears to be less affected by extra renal factors than the 
urea (Le Garreres, Laroute, De la Farge, Boudet, Lefebvre, 2007). The creatinine has many 
features that make it a good marker of the GFR. It is produced at a constant rate from creatine 
in muscle, it is then is distributed homogeneously throughout body water and finally, in the 
nephron, where it is freely filtered without any significant reabsorption or secretion (Watson et 
al., 2002). However, extra renal factors can influence the serum creatinine concentration. Since 
creatinine is produced in the muscle, a decrease in muscle mass can cause a decrease in serum 
creatinine, which is the case of pediatric, geriatric and cachectic animals (Braun, Lefebvre & 
Watson, 2003). The cats’ breed also influence the serum creatinine concentration (Reynolds et 
al., 2010) and, additionally, a gradual increase is noted from new born to adulthood (DiBartola 
& Westropp, 2014; Palm, 2017). In addition, there is also an effect of food: animals fed with a 
meat-based diet have higher concentrations of serum creatinine until 12 hours after the meal, 
suggesting that blood samples should be collected when the animals are fasted (Watson et al., 
2002). 
Concentration of SDMA (Symmetric dimethylarginine) has been shown to be increased in cats 
with CKD and it strongly correlates with an increase in serum creatinine concentrations and a 
decrease in the GFR, revealing itself a new promising endogenous marker of GFR (Nabity et 
al., 2015). SDMA is a byproduct of protein methylation that is released into blood and 
eliminated primarily by renal clearance (<90%) with minor extra-renal influences. Studies have 
demonstrated that SDMA increases when there is a 25 to 40% decrease in GFR and, therefore, 
detects a loss on renal function earlier than the traditional measurement of creatinine (Hall et 
al., 2014; Nabity et al., 2015; Ernst et al., 2018). An elevation of the serum SDMA 
concentration above the normal reference interval was evidenced a mean of 14.6 months before 
the elevation of creatinine (Haall et al., 2014).  However, similar to creatinine, SDMA needs to 
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be interpreted in light of hydration status and physical examination findings but contrary to 
creatinine, SDMA is not affected by muscle mass (Hall et al., 2014; Nabity et al., 2015; Ernst 
et al., 2018). 
Cystatin c is a proteinase inhibitor that is also gaining interest as a new renal marker. Its 
potential in Veterinary Medicine has been showed in some studies (Wehner, Hartmann & 
Hirschberger, 2008; Ghys et al., 2014). This protein has many of the properties required for an 
ideal endogenous GFR marker: a constant rate production, a freely glomerular filtration 
(because of the absence of plasma protein binding), no tubular reabsorption without catabolism 
and no extrarenal clearance (Séronie-Vivien et al., 2008; Ghys et al., 2014). In addition, a low 
intraindividual variability has been showed, and, the measurement of this protein is easy to 
realize, resulting interesting for the clinical use (Ghys et al., 2014). Despite the lack of studies, 
work developed by Wehner et al. (2008) demonstrated that cystatin c had a stronger correlation 
with the exogenous creatinine plasma clearance (r=0.63) compared with serum creatinine 
(r=0.57). Sensitivity for detecting reduced GFR was higher for serum cystatin c (76%) than for 
serum creatinine (65%), yet the serum creatinine had a slightly better specificity (91%) than 
serum cystatin c (87%). The same study showed that nonrenal diseases (such as neoplasia and 
infection) did not influenced the serum cystatin c concentration. Although these results seem 
promising, further investigations are required for the cystatin c to become an adequate 
biomarker (Wehner et al., 2008). 
A compromised renal function may lead to multiple hematological and biochemical 
abnormalities. Phosphorus is excreted primarily via the kidneys so if dietary intake remains in 
a constant rate, a decline in the GFR will lead to his retention and, consequently, to 
hyperphosphatemia. Compensatory decrease in tubular reabsorption maintains a serum 
phosphorus concentration regulated in the early stages of CKD. However, when this 
compensatory adaptation reaches its limit, typically when GFR declines below 20%, the serum 
concentration of phosphorus starts to increase (Polzin, 2011). Low levels of potassium are also 
frequently associated with cats with CKD but are uncommon in dogs (Polzin, 2011). Levels of 
serum calcium can either increase or decrease, yet classically animals with CKD present a 
hypocalcemia (Barber et al., 1998). Indeed, ionized hypercalcemia was reported in 6% and 
ionized hypocalcemia in 26% in cats with spontaneous CKD (Barber et al., 1998). 
The differentiation between acute renal failure (ARF) and chronic kidney disease (CKD) can 
be difficult but they must be discriminated at the moment of diagnosis because they differ in 
therapeutic and prognostic implications, since CKD is generally an irreversible disease while 
ARF has the potential to be reversible. However, ARF and CKD may co-exist in some animals, 
which is called the acute on chronic kidney disease (Polzin, 2013). 
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The ARF is a clinical syndrome characterized by an abrupt increase in serum creatinine and 
BUN concentrations (azotemia) in the absence of chronicity. This ARF leads to a rapid decline 
in renal function with devastating effects if a treatment is not provided in an early phase 
(Langston, 2017). It is more preferable to take appropriate preventive measures in situations 
recognized in which ARF is likely to develop than to treat an established ARF. Frequently, the 
clinicopathologic abnormalities associated with ARF are more severe than those observed in 
CKD since most of the compensatory mechanisms that developed in CKD are not present in 
ARF (DiBartola & Westropp, 2014). 
CKD is defined as structural and/or functional abnormalities of one or both kidneys that have 
been continuously present for 3 months or longer (Polzin, 2013). CKD typically causes a slow 
but inevitably progressive decline in renal function however the rate of this progression is not 
predictable (Hall et al., 2014). While no treatment can correct these irreversible kidney lesions, 
consequences and complications associated can often be ameliorated by supportive therapy and 
thereby slow the progression course of the CKD and successfully manage the disease for 
months or even years in some cats  after the diagnosis (Polzin, 2013).  
Nowadays, clinical practice guidelines for diagnosis, prognosis and managing of CKD are 
based on the stage of the disease. The International Renal Interest Society (IRIS) has proposed 
a system for staging CKD in dogs and cats based on serum creatinine and SDMA concentrations 
and a sub-staging system based on the magnitude of the urine protein creatinine ration (UPC) 
and blood pressure. The stage of the CKD is based on a least 2 measurements of the animal’s 
serum creatinine but ideally these values should be determined over several weeks to confirm 
short-term stability of the kidney function. The UPC is determined after the confirmation that 
neither a urinary tract infection nor a hemorrhage is present and, ideally, it should be measured 
on the basis of at least 2 urine samples collected with a minimum of 2 weeks interval. Regarding 
the systolic blood pressure, this should be determined after multiple measurements in a calm 
animal and, preferentially, repeated on separate days. (IRIS, 2017). 
On the other hand, ARF is classified in 5 grades based on creatinine concentration and is further 
sub-classified as non-oliguric or oligo-anuric patients; or cases requiring renal replacement 
therapy. Contrary to IRIS staging for CKD, the ARF grades represent a moment in the course 
of the disease and need to be reevaluated regularly, during hospitalization (IRIS, 2016).  
2.4 Ureteral obstruction  
Ureteral obstruction is a challenging disorder often requiring highly sophisticated diagnostic 
and therapeutic measures as well as unique surgical skills (Shipov & Segev, 2013). This 
disorder has been diagnosed more often all over the world, for the past decades (Kyles et al., 
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2005a; Osborne, Lulich, Kruger, Ulrich & Koehler, 2008). The increased number of cases may 
be explained by the use of new diagnostic imaging modalities and increase awareness of the 
severe consequences of ureteral obstruction (Osborne et al., 2008). These factors combined 
with the morbidity and mortality resulting of the traditional surgical techniques make the use 
of new interventional alternatives appealing (Kyles et al., 2005b).  
2.4.1 Signalment 
Ureterolithiasis is a major cause of ureteral obstruction in dogs and cats (Selgev, 2011). 
Urolithiasis is a multifactorial syndrome where familial, congenital or acquired 
pathophysiologic factors that progressively increase the risk of precipitation of excretory 
metabolites in the urine (Osborne et al., 2008).  
Evaluation of breed, gender and reproductive status predisposition by Lekcharoensuk et al. 
(2000) showed that British Shorthair, Exotic Shorthair, Foreign Shorthair, Havana Brown, 
Himalayan, Persian, Ragdoll and Scottish Fold cats have an increased risk of developing 
calcium oxalate uroliths as well as male cats and neutered cats. On the other hand, magnesium 
ammonium phosphate uroliths (struvite) are more prevalent in Chartreux, Domestic Shorthair, 
Foreign Shorthair, Himalayan, Oriental Shorthair and Ragdoll cats as well as female and 
neutered cats. The same study demonstrated that cats between 7-10 years old are more likely to 
develop calcium oxalate uroliths while struvite uroliths seem more frequent in younger cats, 
with age between 4-7 years old. 
The lifestyle of the cat is also a risk factor associated to urolithiasis since indoor cats have less 
physical activity and, consequently, a reduced water consumption and low urine debit, 
facilitating the urinary minerals to precipitate (Gomes, Ariza, Borges, Schulz & Fioravanti, 
2018). 
2.4.2 Etiology of ureteral obstruction in dogs and cats 
A correct classification of the ureteral obstruction is essential since the treatment plan is 
different depending on the nature of the obstruction along with the animal’s medical condition. 
Ureteral obstruction can be classified as acute or chronic, unilateral or bilateral, partial or 
complete, static or dynamic (Shipov & Segev, 2013). The more frequent obstructions are partial 
and unilateral, especially those induced by ureteroliths (Kyles et al, 2005a; Adams, 2017).  
Concerning its etiology, ureteral obstructions may also be caused by congenital or acquired 
diseases. Although congenital causes are rare, it includes ureteral stricture (Pullium, Dillehay, 
Webb, & Pinter, 2000), ureterocele and segmental ureteral aplasia (Lamb, 1998). Despite the 
fact that, a circumcaval ureter by itself does not cause a ureteral obstruction, this condition may 
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potentially induce a ureteral stricture, which may progress to obstruction. As a matter of fact, 
ureteral obstructions in cats with a circumcaval ureter were caused by a ureteral stricture in 40% 
of cases, while the remaining 60% of cases had a ureteral calculi (Steinhaus et al., 2015). 
Concerning acquired causes, they are usually due to mechanical obstruction of ureters. This can 
result from an intraluminal obstruction, an intramural lesion or an extraluminal compression 
(Hardie & Kyles, 2004).  
Intraluminal obstruction is the most common cause of ureteral obstruction in dogs and cats and 
is usually caused by ureterolithiasis. However, blood clots or other inflammatory debris may 
also obstruct the ureter, particularly in cats (Selgev, 2011).  
Intramural causes include ureteral stricture, ureterocele, neoplasia, proliferative ureteritis and 
fibroepithelial polyps. Among those, ureteral stricture seems to be the most frequent cause of 
intramural ureteral obstruction. Strictures can have various origins: a previous ureteral surgery, 
calculi embedded in the ureteral mucosa or, as already mentioned, congenital (Shipov & Segev, 
2013). Neoplasia can be primary or metastasic. Although rare in dogs and cats, reported primary 
ureteral neoplasia include fibropapilloma, leiomyoma, leiomyosarcoma and transitional cell 
carcinoma (Hardie & Kyles, 2004; Adams, 2017). 
Extramural compression may occur from retroperitoneal space occupying lesions (as masses), 
circumcaval ureter (Adams, 2017), urinary bladder pathology or from accidental surgical 
ligation of the ureter during ovariohysterectomy (Selgev, 2011). 
2.4.3 Pathophysiology   
The physiologic response to ureteral obstruction is extremely complex and after the relief of 
the obstruction, changes continue to occur in the previously obstructed kidney. The 
development of adverse events on the kidney depend on the specie, age, degree of obstruction, 
duration and whether or not the obstruction is unilateral or bilateral (Hardie & Kyles, 2004).  
The longer the duration of the obstruction, the greater the potential for progressive irreversible 
damage. Therefore, a complete and prolonged obstruction will lead to renal fibrosis and 
atrophy. For instance, in normal dogs, after 1 week and 2 weeks of obstruction the GFR is 
permanently diminished by 35% and 54%, respectively (Wen, Frokiaer, Jorgensen & Djurhuus, 
1999). An acute situation has the potential to be reversible and these changes may not occur or 
be incomplete if the obstruction is treated in time. Yet a complete and bilateral obstruction may 
be fatal within 48-72 hours (Adams, 2017). 
The obstruction increases immediately the ureteral and renal pelvis pressure which is 
consequently transmitted to nephrons. When the pressure is high enough, it is accompanied by 
a decrease in the renal blood flow and in local GFR while a compensatory increase in the 
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contralateral kidney GFR occurs. Therefore, if the contralateral renal function is preserved, the 
animal is not expected to become azotemic and clinical signs, if present, are mostly pain related 
due to the stretching of the renal capsule. Due to the unspecific clinical signs, these episodes of 
unilateral ureteral obstruction often go unnoticed by owners. However, this compensatory 
mechanism may not occur in animals with pre-existing CKD (Shipov & Segev, 2013). 
With time, a leukocyte influx into the ipsilateral kidney also occurs, leading to a fibroblast 
recruitment and activation that contributes to a development of an interstitial fibrosis or 
glomerulosclerosis (Wen et al., 1999). If the contralateral kidney function is preserved, the 
kidney undergoes a compensatory hypertrophy, which may result in the “big kidney, little 
kidney syndrome” (Selgev, 2011). 
The mechanical obstruction also induce a secondary local inflammation, edema and spasm of 
the ureteral muscle which exacerbates the clinical presentation (Selgev, 2011). Furthermore, it 
is worth noticing that, a dynamic obstruction caused by ureteral spasm has the potential to 
resolve itself spontaneously (Selgev, 2011). 
2.4.4 Uroliths composition 
Determining the urolith composition is a useful tool, given that it is important to prevent a 
recurrence and some diets may be instituted in order to reach that goal (Bartges & Callens, 
2015). In cats, the reported recurrence rate for ureteroliths is 40% (Kyles et al., 2005b) and from 
the recurrent uroliths, 3.5% of them had a different mineral composition compare to the initial 
episode (Albasan et al., 2009). Therefore, in interventions where ureteroliths can be removed, 
all uroliths should be analyzed to determine its mineral composition and, moreover, recurrent 
uroliths must be resubmitted (Bartges & Callens, 2015).    
The most common feline uroliths types are struvite and calcium oxalate, both representing 
almost 90% of 94778 feline uroliths analyzed in the Minnesota Urolith Center (Osborne et al., 
2008). The majority of uroliths submitted were composed of calcium oxalate (49%) and struvite 
(41%). Purine-based uroliths (urate and xanthine) represent approximately 5% of uroliths, with 
a relatively stable prevalence over the years. Of the totality of uroliths submitted, 5% were 
composed of “other substances”, such like matrix and calcium phosphate (Osborne et al., 2008). 
However, these values are concerning uroliths from all urinary tract. In a study by Kyles et al. 
(2005a), 93 ureteroliths were analyzed, in which 98% contained calcium oxalate.  
Hypercalciuria promotes the formation of calcium oxalate uroliths, and multiple causes may be 
involved, such as idiopathic hypercalcemia, primary hyperparathyroidism, neoplastic disease, 
increased bone demineralization and an impaired renal tubular reabsorption of calcium (Palm 
& Westropp, 2011; Milligan & Berent, 2019). In a study by Berent, Weisse, Bagley & Lamb 
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(2018), 21% of cats were diagnosed with an idiopathic hypercalcemia, at some time after the 
surgery. Certain medications may also promote a hypercalciuria including loop diuretics and 
corticosteroids, as well as dietary factors like an increased intake of calcium and vitamin D and 
urinary acidifiers diets (Milligan & Berent, 2019).  
Relative supersaturation (RSS) is a risk index of crystallization and it is important in the urolith 
formation. Uroliths typically form in an oversaturated urine with respect to the minerals that 
precipitate to form that type of urolith (Lulich, Osborne, Carvalho & Nakagawa, 2012; Bartges 
& Callens, 2015). The crystallization risk may be assessed indirectly by the urine pH, USG and 
microscopic evaluation (Queau, 2019). An increased urine concentration as well as a reduced 
water consumption therefore predispose to calculi formation, since it leads to the stagnation of 
the urine and restrains the crystals elimination (Milligan & Berent, 2019).  
The urinary acidifiers diets are typically employed for the dissolution and prevention of struvite 
uroliths, however, it may promote calcium oxalate crystalluria because of the release of calcium 
carbonate and calcium phosphate from the bone, resulting in hypercalciuria (Osborne et al., 
2008; Palm & Westropp, 2011). However, the effect of urine pH remains controversial. Several 
studies about the effect of acidic urine on the RSS of calcium oxalate diverged, showing that 
the acidity may increase the RSS (Bartges, Kirk, Cox & Moyers, 2013) or maintain it (Queau 
et al., 2013).  
A study conducted by Lekcharoensuk et al. (2001) evaluated the association between dietary 
factors and the occurrence of calcium oxalate and struvite uroliths. The results suggested that 
diets with high protein, sodium, potassium, moisture, phosphorus and magnesium decreased 
the risk of calcium oxalate uroliths. This study also reported that, cats fed with moderate 
calcium-containing diets, were less likely to form calcium oxalate uroliths when compared to 
cats fed with lower and higher concentrations of calcium. Therefore, this study revealed that 
restriction of dietary calcium is a risk factor for calcium oxalate urolithiasis, contradicting the 
opposite prevailing consensus. Further investigation is needed in order to evaluate the influence 
of dietary calcium in the formation of calcium oxalate. At last, the same study showed that, in 
order to minimize the formation of struvite uroliths, diets should be formulated to contain higher 
fat content and lower protein and potassium concentrations (Lekcharoensuk et al., 2001). 
2.4.5 Ureteroliths distribution  
The number and location of ureteroliths within the ureter is an important consideration when 
deciding for the most appropriate treatment, yet there is still a lack of veterinary literature 
regarding this subject.  The identification of concurrent renal and cystic calculi is also essential 
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in therapeutic decision. One study documented that, in addition to ureteral calculi, 62% of cats 
had renal calculi whereas 9% had cystic calculi (Kyles et al., 2005a).  
Another study by Nesser, Reetz, Clarke & Aronson (2018) reported that ureteroliths were more 
frequently situated in the proximal and mid ureter than in the ureterovesicular junction (UVJ), 
both in cats with single and multiple ureteroliths. Additionally, also a correlation between 
ureterolith size and location has been evidenced, with larger ureteroliths associated with a more 
proximal ureteral location, which may be due to the small ureteral luminal diameter in cats. 
Furthermore, the UVJ is a very small region of the ureter, compared with the mid ureter, which 
may explain the reduced number of ureteroliths in this region (Nesser et al., 2018).  
The position of a ureterolith can also quickly change within the ureter, either by a normograde 
movement towards the urinary bladder, or a retrograde movement. Therefore, ureteroliths 
position identified at one moment may not correspond to their current position (Nesser et al., 
2018). 
Future studies are required to further evaluate the anatomy of the cat’s ureter, in order to 
determinate if there is a presence of another anatomic or functional narrowing leading to a more 
frequent calculi lodgment in some regions, as seen in humans (Nesser et al., 2018). 
2.4.6 Anamnesis and clinical signs 
The presentation of cats with ureteral obstruction varies substantially from one patient to the 
other and clinical signs may not be apparent unless a bilateral obstruction or a unilateral 
obstruction with combination with a compromised function of the contralateral kidney occurs. 
In some cases, the ureteral calculi can be an incidental finding during abdominal imaging for 
unrelated reasons (Shipov & Segev, 2013). 
Clinical signs are generally nonspecific including weight loss, reduced appetite and lethargy 
(Kyles et al., 2005a). If the animal is severely azotemic, signs of uremia can occur, namely 
vomiting, anorexia, polyuria and polydipsia. Signs directly referable to ureteral obstruction can 
also be present namely hematuria, oliguria, anuria and abdominal pain (Selgev, 2011). On 
physical examination, pallor of the mucous membranes, dehydration, asymmetrical kidneys and 
abdominal pain may also be found (Berent, 2011). These clinical sign contribute to the difficulty 
to diagnose and provide strict therapeutic guidelines to this heterogeneous group of patients 
(Shipov & Segev, 2013). 
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2.4.7 Laboratorial abnormalities  
A study conducted by Kyles et al. (2005a) reported that 83% of the cats diagnosed with ureteral 
calculi were azotemic, with serum creatinine and BUN concentrations significantly higher in 
cats with bilateral ureterolithiasis compared with cats with unilateral ureterolithiasis.  However, 
76% of the cats with unilateral ureterolithiasis presented with azotemia, indicating that the renal 
function of the contralateral kidney was also compromised (Kyles et al., 2005a). In the same 
study, 54% of cats had hyperphosphatemia, 35% hyperkalemia, 22% hypocalcemia and 14% 
hypercalcemia. Cats frequently had a normocytic normochromic anemia at diagnosis (48%) 
(Kyles et al., 2005a) and this was either due to an underlying CKD, chronic inflammation (as 
some cats may have had a concurrent pyelonephritis) or excessive blood sampling during 
previous hospitalizations (Shipov & Segev, 2013). 
Urinalysis often does not provide specific information in ureteral obstructions but may reveal 
hematuria, pyuria, cylindruria, crystalluria and bacteriuria (Shipov & Segev, 2013).  However, 
crystalluria is not a consistent feature of urinalysis in cats with uroliths since uroliths can be 
present without crystalluria and, when present, crystalluria may not accurately predict the 
urolith type (Labato, 2017). The urine samples should be analyzed as soon as possible to prevent 
a false positive crystalluria considering that changes in temperature and elapsed time between 
urine collection and urinalysis may induce crystalluria (Bartges & Callens, 2015). The value of 
pH may help predicting the type of urolith present since struvite, calcium carbonate and calcium 
phosphate are less soluble in alkaline urine while ammonium urate, silica and cysteine are less 
soluble in acid urine (Labato, 2017). Low-grade metabolic acidosis associated with aciduria 
increases calcium resorption from bone and therefore urinary calcium excretion. Furthermore, 
acidic urine may decrease the action of citrate and pyrophosphate as calcium oxalate inhibitors. 
Lastly, calcium is also less reabsorbed from the distal tubule when the urine is acidic (Labato, 
2017). 
Bacteriuria was found in 25% of cats, with the most frequently isolated bacteria being 
Escherichia coli (Berent et al., 2018). 
2.4.8 Imaging modalities 
The diagnosis of ureteral obstruction in cats can be challenging and it is based on the history, 
clinical signs and laboratorial abnormalities, and is resorting to the use of imaging techniques 
to confirm the diagnosis (Selgev, 2011).   
Ultrasonography is a useful tool to determine the degree of hydroureter, hydronephrosis and 
the exact location of ureteroliths, as seen in figure 3 and 4 (Lamb et al., 2018). It has the added 
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benefit of allowing the clinician to assess to the renal geometry and architecture and it is a 
valuable tool when suspecting tissue lesions, such as strictures and neoplasia (Shipov & Segev, 
2013). If a hydroureter is present without evidence of a shadowing ureterolith and with the peri-
ureteral tissue hyperechoic, then a ureteral stricture should be considered (Zaid, Berent, Weisse 
& Caceres, 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Work developed by D’Anjou, Bébard and Dunn (2011) has shown that cats with clinically 
normal renal function not receiving IV fluids may have a pyelectasia reaching 3 mm. 
Nevertheless, the medians for maximal renal pelvic width were 1.6mm for cats with a clinically 
normal renal function and 2.3mm for cats with a clinically normal renal function with diuresis 
(D’Anjou et al., 2011). Knowing the exact diameter of the renal pelvis is a key piece of 
information, because it is important to decide which interventional option is best for each 
animal (Berent, 2011).  
Radiographs, as showed in figures 5 and 6, are extremely useful to document uroliths size, 
number and location, since these are often underestimated with ultrasound (Berent, 2011). The 
radiopaque calculi that can be visualized with radiographs including calcium oxalate, struvite, 
apatite and silica while ammonium urate and cysteine are nonmineralized uroliths and thus not 
visible with radiographs, except if mixed with mineralized uroliths (Labato, 2017). However, 
ureteroliths smaller than 2 mm, which are common in cats, may be missed in the radiographs 
(Lulich & Osborne, 2008). 
 
Figure 3 and figure 4. Abdominal ultrasonographies showing a hydroureter and ureteral 
calculi (original, kindly provided by the CHV-Frégis). 
Legend: Left frame: ureter measuring 1.2mm with a hyperechogenic element of 1.3mm located 
in the mid ureter. Right frame: hyperechogenic element with an acoustic shadow. 
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The accuracy of survey radiography or ultrasonography for detecting feline ureteral calculi is 
only moderate, with false negative and false positive results recorded in both modalities. The 
sensitivity of radiography and ultrasonography for the diagnosis of feline ureteral calculi is 
estimated to be 81% and 77%, respectively, while the combination of both modalities increase 
the sensitivity to 90%, emphasizing the importance of combining these tools (Kyles et al., 
2005a). Despite that, there is a good agreement between radiographic and ultrasonographic 
findings and discrepancies probably reflect moments in which calculi is present but not 
observed. Calculi may be missed ultrasonographically if the ureter cannot be adequately 
examined or missed radiographically if there is superimposition by other structures or if the 
calculi are not sufficiently opaque or large. In order to have a better visualization of the urinary 
tract, an enema is necessary in some patients (Lamb, Cortellini & Halfacree, 2018). 
If ureteral obstruction is highly suspected but the obstruction cannot be evidenced using 
radiography or ultrasound, contrasts studies or computerized tomography (CT) could be 
considered (figure 7) (Etedali, Reetz & Foster, 2019). 
 
 
 
 
 
 
 
 
 
Figure 5 and figure 6. Dorsoventral and lateral view radiographs of a cat with bilateral 
ureteolithiasis (original, kindly provided by the CHV-Frégis). 
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Intravenous excretory urography offers several advantages, providing information related to the 
renal vasculature, size and shape of the urinary tract. Although complications are rare, there are 
some reported cases of contrast medium-induced nephropathy by intravenous administration of 
the contrast material (Etedali et al., 2019). Furthermore, since the GFR is decreased in most 
cases of ureteral obstruction, there is a diminution of contrast elimination through kidneys and 
it may not be sufficient to make the diagnosis (Shipov & Segev, 2013).  
Contrast CT scans are also useful for confirmation of the number and location of the 
ureteroliths, strictures, neoplasia or extramural compressive lesions, as well for distinction 
between partial and complete obstructions (Berent, 2011; Adams, 2017).  
Alternatively, a percutaneous antegrade pyelography can be done to confirm a ureteral 
obstruction, when a sufficient pyelectasia is present. This technique provides good filling of the 
renal collecting system, regardless of the renal function, with a high sensitivity and specificity 
for the diagnosis of feline ureteral obstruction. The contrast is injected under ultrasonographic 
or fluoroscopic guidance, decreasing the risk of nephrotoxicity by avoiding systemic 
administration of the contrast. Before the contrast’s injection, urine may be collected and sent 
for culture. Complications associated with this technique include leakage of contrast material, 
hemorrhage and blood clot formation (Etedali et al., 2019). Another option is a retrograde 
ureteropyelography, performed via cystoscopy and fluoroscopy, by injection of the contrast in 
the ureterovesicular junction (UVJ) with a retrograde progression of a higher concentration of 
the contrast’s material (Berent, 2011). 
Legend: Transverse 5 mm sections of the abdomen of the cat were obtained. The CT slice shows a 
radiopaque calculi in the left kidney and proximal ureter (white arrow). 
 
Figure 7. Computerized tomography study of a cat with ureterolithiasis (adapted from 
Hardie & Kylies, 2004).  
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2.4.9 Treatment 
Ureteral obstructions require immediate care, in order to prevent a decrease in renal function, 
regardless of whether the obstruction is partial or complete (Lulich et al., 2016). The urgency 
and therapeutic intervention are determined by the nature of the obstruction (if it is static or 
dynamic), its location, presence and severity of clinic and laboratorial abnormalities (such as 
hyperkalemia) and the existence of urinary tract infection, while considering the risks 
associated with each one of the interventions (Kyles et al., 2005b). The clinician is challenged 
to consider more often less invasive alternatives. However, not all management strategies are 
appropriate for every animal or situation (Lulich et al., 2016).  
2.4.9.1 Medical treatment 
In cats with obstructive ureteroliths, a medical therapy should be considered as a first-line 
treatment for the relief of the obstruction. Nevertheless, medical treatment should not be 
continued in cats with progressive azotemia, persistently oliguric, anuria, hyperkalemic or with 
a progressive ureteral and renal pelvis dilatation (Lulich et al., 2016; Adams, 2017).  
Medical dissolution may be applied in non obstructive uroliths, such as struvite, urate, cystine 
uroliths. Nevertheless, since the most common type of ureteroliths in cats is calcium oxalate, 
which are not amenable to medical dissolution, this therapy should not be attempted in cats 
arriving for medical care with an obstructive upper urinary tract urolith (Lulich et al., 2016).  
Medical expulsive therapy (MET) may be part of the management of ureteroliths as an attempt 
to facilitate its passage by increasing the urine flow, while simultaneously monitoring the 
ureterolith’s position and animal’s condition (Adams, 2017). This medical therapy should be 
initiated immediately following the diagnosis, as a medical stabilization before a surgical 
procedure. Medical management should consist of aggressive intravenous fluid therapy with a 
close monitoring of the hydration status, electrolyte concentrations, body weight and possible 
cardiac disease, since it is not unusual for cats to become fluid overloaded (Berent, 2011). In 
addition, the use of an osmotic diuretic can be considered and, therefore, a constant rate infusion 
(CRI) of mannitol can be started, in cats without concurrent cardiac compromise (Berent, 2014; 
Lulich et al., 2016). 
Other medical alternatives have been used with anecdotal reports of improvement in some cases 
and, consequently, drugs such as amitriptyline, prazosin and glucagon can be considered in 
addition to the MET (Berent, 2014; Lulich et al., 2016). In one report, amitriptyline has proved 
to be a potent, rapid and extremely effective blockade of the urinary smooth muscle contractions 
facilitating the passage of urethral plugs in cats, however there are no clinical reports supporting 
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its use for ureteroliths (Achar, Achar, Paiva, Campos & Schor, 2003). In another study with 18 
cats with ureterolithiasis, the administration of glucagon resulted in the movement of the urolith 
in only 4 cases. However, it was associated with a high number of side effects (Forman, 
Francey, Fischer & Cowgill, 2004). Pain management is also very important, to decrease the 
ureteral spasm (Berent, 2014). 
Despite all of this, medical treatment for obstructive ureterolithiasis rarely result. Reported 
effective results occurs in only 8 to 13% of cases. Therefore, it is very important that owners 
are informed of this high rate of medical failure (Kyles et al., 2005b; Lulich et al., 2016). 
When attempting for medical management, a risk for irreversible renal damage during the 
treatment should be considered, and this is one reason why medical management can only be 
applied for a very short period of time. Considering that the obstruction is frequently already 
present before the admission in hospital, this period of time may be even shorter to prevent 
irreversible damage. Since there is a high probability of recurrence of ureterolithiasis in cats, 
the benefits of potentially avoiding surgery must be weighed against the risks of the medical 
treatment and, above all, the renal function should be preserved (Shipov & Segev, 2013). 
Therefore, if the medical management fails over 24-72h, or the animal is not stable, presenting 
a hyperkalemia, overhydration, oliguria/anuria or a progressive hydroureter/hydronephrosis, an 
immediate renal decompression must be considered (Berent et al., 2014; Lulich et al., 2016). 
Nevertheless, intervention only should be considered if an experienced operator is available 
since a higher complication rate is associated with less experienced operators (Lulich et al., 
2016). If an immediate resolution is not possible or the animal is too unstable, then the clinician 
can consider placing a nephrostomy catheter or initiate intermittent hemodialysis or a 
continuous renal replacement therapy (CRRT), when available (Berent et al., 2014).   
Appropriate treatment of clinical signs and laboratory abnormalities should also be provided as 
necessary, such as antibiotic, antiemetic, among other (Berent et al., 2014). 
2.4.9.2 Surgical treatment 
2.4.9.2.1 Preoperative management  
General anesthesia may be damaging for animals with a pre-existing renal disease since nearly 
every anesthetic agent causes a decrease in the GFR and renal blood flow. Consequently, 
measures should be taken in order to minimize any detrimental impact to the remaining renal 
function during surgery (Weil, 2010).   
Before the general anesthesia, efforts should be made to reduce the level of azotemia, correct 
the dehydration, electrolyte disturbances as well as acid-base disorders, since, a high serum 
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creatinine concentration and hyperkalemia at the preoperative period were found to be strongly 
associated with mortality after surgical correction of the ureterolithiasis (Mateo, Brodbelt, 
Kulendra & Alibhai, 2015). A careful evaluation of the fluid therapy of these animals is crucial, 
especially in anuric or oliguric cats who can become fluid overloaded. Anemia should also be 
identified and corrected if clinically needed before general anesthesia because it may potentially 
lead to a failure in the distribution of oxygen to tissues (Weil, 2010). 
A potential for drug overdose may also occur since anesthetic drugs that are renally excreted 
could be affected by a decrease in renal excretion, making the selection of appropriate analgesic 
and anesthetic drugs and dosages, critical (Mateo et al., 2015). Release of catecholamine is 
produced in painful and stressful animal, which can lead to a decreased blood flow to the 
kidney. Therefore, a premedication with sedatives and analgesics can be very helpful in these 
animals. According to the guidelines from the International Society for Companion Animal 
Infectious Diseases (ISCAID), an antimicrobial prophylaxis with a 1st or 2nd generation 
cephalosporin is recommended, no more than 60 minutes before the surgery (Weese et al., 
2019). For induction and maintenance of the surgery, propofol may be beneficial for cats with 
ureterolithiasis as it has minimal effects on the GFR (Weil, 2010). Isoflurane or sevoflurane 
may be used for maintenance, since these volatile anesthetics maintain an adequate renal blood 
flow (Weil, 2010).  
The duration of general anesthesia should be minimized whenever possible, as a longer 
anesthesia time has been associated with hypothermia and the development of intraoperative 
complications (Redondo et al., 2012; Mateo et al., 2015; Deroy et al., 2017). ). Hypothermia 
should be prevented by using various heating methods because it can lead to several negative 
consequences, including arrhythmias, coagulopathies and reduced oxygen delivery to tissues 
(Clark-Price, 2015). Hypothermia was the most common anesthetic related complication 
(93%), which is found especially in cats, due to its large surface area in relation to body weight 
(Luca, Monteiro, Dunn & Steagall, 2017). Hypotension is also a common consequence of a 
prolonged anesthesia, found in 82% of cats, which should be prevented since it may lead to 
hypoperfusion and, consequently, to a decreased renal blood flow and reduced GFR (Kulendra 
et al., 2014; Livet et al., 2017; Luca et al., 2017). Livet et al. (2017) reported a severe 
hypotension in one cat that ended up in euthanasia, the day after surgery. Therefore, in order to 
avoid this, it is essential to provide fluid therapy, as well as a judicious anesthetic monitoring 
with early management of intraoperative anesthetic related complications (Luca et al., 2017). 
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2.4.9.2.2 Traditional interventions 
Renal decompression in cats may be realized traditionally, with procedures such as 
ureterotomy, ureteronephrectomy, ureteroneocystostomy and renal transplantation. However, 
these traditional interventions are associated with relatively high rates of complications and 
mortality, as well as persistent ureteral obstructions (Kyles et al., 2005b; Berent, 2011; Culp et 
al., 2016). The procedure performed depends on a multitude of factors, including the cause of 
the ureteral obstruction, location, presence of concurrent urinary tract illness and clinician 
preferences (Wormser, Clarke & Aronson, 2016).  
A renal transplantation should be reserved for patients with irreversible azotemia and not 
necessarily for post renal azotemia caused by a ureteral obstruction (Berent, 2011).  
It is also important to realize that a ureteronephrectomy is not an ideal treatment of feline 
ureterolithiasis, especially in cats with concurrent renal azotemia, because of the importance of 
preserving all renal function, whenever possible (Berent, 2011). Moreover, there is also a 
significant risk of recurrence of the obstruction in the contralateral kidney/ureter (Kyles et al., 
2005b).  
In a study conducted by Kyles et al. (2005b), where cats with ureterolithiasis were treated with 
traditional surgeries, there was a reported perioperative (since the recovery from anesthesia 
until 7 days after surgery) mortality rate of 18% and postoperative complications were 
described in 30% of cats. The traditional surgeries employed in this study included ureterotomy, 
ureteroneocystostomy, ureteronephrectomy and renal transplantation. An ureterotomy was 
preferred for removal of calculi in the proximal portion of the ureter, whereas an 
ureteroneocystostomy was more likely to be performed for a calculi presented in the distal 
portion of the ureter. The most common complications were urine leakage (16% and 15% for 
ureterotomy and ureteroneocystostomy, respectively) and persistent ureteral obstruction (3% 
and 11% for ureterotomy and ureteroneocystostomy, respectively). Despite these elevated rates, 
the surgeries were performed in 2 universities that had extensive expertise with ureteral surgery, 
consequently, higher morbidity and mortality rates may be found in clinics with less 
microsurgical experience. 
A more recent study by Culp et al. (2016) evaluated the outcome of ureterotomy, reporting that 
only 78% of cats survived to hospital discharge and only 31% had a resolved azotemia after the 
surgery; and overall, postoperative improvement of laboratorial parameters was not as 
pronounced as it was for cats treated with ureteral stenting. Moreover, the most frequent 
complication was urine leakage, presented in 33% of cats, which leaded to a uroabdomen. These 
cats were significantly less likely to survive. 
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Other complications associated with these traditional surgeries include site edema, re-
obstruction from nephroliths that pass to the surgery site, stricture formation and missed 
ureteroliths that are not removed (Kyles et al, 2005b; Milligan & Berent, 2019).  Moreover, the 
ureteral surgery may result in a temporary postoperative obstruction of the ureteral lumen due 
to the mucosal edema at the ureterotomy site (Adams, 2017). It is crucial to ensure that all 
ureteroliths are removed, as some of small sizes may be difficult to palpate digitally during the 
surgery and may passed unnoticed, resulting in a continuous ureterolithiasis (Berent, 2011; 
Adams, 2017).  
The presence of nephroliths could be a risk factor for reobstruction of the ureter since they have 
the potential to eventually pass into the ureter and obstruct it. Kyles et al. (2005b) reported that, 
40% of cats had a recurrent ureterolithiasis within 2 years after the traditional ureteral surgery 
for the management of the initial ureteral obstruction and, 86% of these had evidence of 
nephrolithiasis on the initial imaging. However, cats which had already an episode of 
ureterolithiasis were probability more likely periodically evaluated by means of diagnostic 
imaging studies, whereas other cats may had undiagnosed episode of nephrolithiasis (Kyles et 
al., 2005b).  
Therefore, in the opinion of Adams (2017), ureterotomy or ureteroneocystostomy should only 
be considered for the removal of solitary ureteroliths, without concurrent presence of ureteral 
stricture. 
Given the potential complications and mortality associated with these traditional surgeries, 
alternatives have been investigated for animals over the past years. The ideal would be to find 
a less invasive technique that leads to an immediate renal decompression and stabilization of 
the azotemia while simultaneously preventing postoperative complications (Berent, 2011; 
Milligan & Berent, 2019). 
2.4.9.2.3 Alternative interventions 
Due to the small luminal diameter of feline ureters, available options for treatment are reduced, 
and ureteral stents and Subcutaneous Ureteral Bypasses (SUB) have been developed to 
overcome the limitations of traditional techniques for the management of ureterolithiasis in cats 
(Hardie & Kyles, 2004; Berent, Weisse, Todd & Bagley, 2014; Deroy, Rossetti, Ragetly, 
Hernandez & Poncet, 2017). Such devices are considered, by the consensus from the American 
College of Veterinary Internal Medicine (ACVIM) as first choice for the best possible outcome 
of obstructive ureteroliths in cats. Furthermore, fluoroscopic imaging, proper training and 
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experienced operator are recommended, in order to optimize the animal’s outcome (Lulich et 
al., 2016). 
2.4.9.2.3.1 Ureteral Stents  
Ureteral stents may be placed cystoscopically, by a percutaneously approach or open surgery. 
This is accomplished via pyelocentesis (normograde way), via cystotomy (retrograde way) or 
through an ureterotomy. In cats, most ureteral stents are placed surgically and using a 
normograde technique (Berent, 2011; Culp et al., 2016; Adams, 2017).  Despite that, in some 
cases, ureterotomy was still required to allow the stent to pass through the obstructed region, 
leading to an increase risk for postoperative urine leakage at this site (Culp et al., 2016). 
After the placement of ureteral stents, these permit the immediate passage of urine through the 
stent lumen (figure 8) and, over time, causes a passive dilatation of the ureter facilitating the 
passage of urine, crystals, uroliths and other debris through the ureter (Culp et al., 2016). This 
ureteral dilatation is also beneficial for cats with ureteral strictures (Berent, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Complications resulting from ureteral stenting were mostly minor and in lower rates than those 
reported with traditional ureteral surgery (Berent et al., 2014). The reported complications rate 
is approximately 9% to 17% in the postoperative period, 9% until 30 days after the surgery and 
33% in the long-term period, with a postoperative mortality of approximately 8 to 18% 
Legend: a double-pigtail ureteral stent was placed to bypass nephroliths and ureteroliths 
(black arrow). 
Figure 8. Postoperative lateral view radiograph showing placement of a double-pigtail 
ureteral stent (adapted from Deroy et al., 2017). 
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(Horowitz, Berent, Weisse, Langston & Bagley, 2013; Berent et al., 2014; Kulendra, Syme, 
Benigni & Halfacree, 2014; Culp et al., 2016; Wormser et al., 2016; Deroy et al., 2017).  
The most frequently described complications were signs of dysuria (pollakiuria or stranguria) 
in 35% to 48% of cats and a ureteral stent exchange was needed in 27% to 44% of cats, which 
was more frequent in cats with ureteral stricture (Berent et al., 2014; Kulendra et al., 2014; 
Wormser et al., 2016; Deroy et al., 2017). Signs of dysuria reported in cats were typically 
temporary and resolved spontaneously or with medical management, normally consisting in 
steroid administration or α-adrenergic blockage (Lamb, Vowler, Johnston, Dunn & Wiseman, 
2011; Berent et al., 2014). The exact cause of these signs remains unclear. Nevertheless, it is 
thought to be caused by the irritation of the distal pigtail of the stent in the trigone region and 
proximal urethra and by ureteral smooth muscle spasm (Lamb et al., 2011). The stent’s material, 
position of the stent and extra length that remains inside the urinary bladder may also contribute 
to the origin of dysuria (Berent et al., 2014; Deroy et al., 2017). A ureteral stent exchange was 
required due to a reobstuction of the ureter, and consequently stent occlusion, in 19% of cats, 
stent migration in approximately 6% of cats and because of stent irritation in 3% of cats (Berent 
et al., 2014). Fracture and encrustation (which also leads to a device occlusion) of the ureteral 
stent may also occurs (figure 9), demanding a stent exchange (Kulendra et al., 2014).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: double-pigtail ureteral stent removed from a cat with an obstructive ureterolithiasis several 
months after placement because of encrustation.  
Figure 9. Retrieved double-pigtail ureteral stent with extensive mineralization (adapted from 
Deroy et al., 2017).  
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Urine leakage was also a common complication of ureteral stenting, being described in 
approximately 15 to 23% of cats (Kulendra et al., 2014; Culp et al., 2016; Deroy et al., 2017). 
Similarly, cats who developed a uroabdomen postoperatively because of urine leakage were 
significantly less likely to survive (Culp et al., 2016).   
Another common complication is chronic lower urinary infection, diagnosed in 11% of cats in 
a study conducted by Wormser et al. (2016). In fact, infection was significantly more common 
in cats with a ureteral stent than in cats that underwent a ureteral surgery. Contrary to Humans, 
ureteral stents are usually left in place long-term in cats and it has been established that the 
incidence of stent related urinary tract infection is directly related to the duration of stenting. 
Once the device is colonized by bacteria, a biofilm formation may occurs, which makes the 
infection clearance more challenging (Klis, Korczak-Kozakiewicz, Denys, Sosnowski & 
Rozanski, 2009). Clinicians should carefully considered this when opting for ureteral stenting, 
and owners should be informed about the infection risk and possible need for a device 
replacement or removal (Wormser et al., 2016) 
The median survival time of cats treated with ureteral stenting was between 419 and 498 days 
and the degree of residual renal function is vital since cats with  CKD IRIS stage I and II lived 
longer than cats with CKD IRIS stage III and IV (Horowitz et al., 2013; Berent et al., 2014; 
Kulendra et al., 2014).  
Contemplating the results of these recent studies, ureteral stenting may be considered as an 
effective treatment of feline ureterolithiasis with postoperative morbidity and mortality rates 
lower that those reported with traditional ureteral surgery (Berent et al., 2014). Nevertheless, 
the outcome of ureteral stenting are more successful for dogs than for cats (Berent, 2011). 
2.5 Subcutaneous Ureteral Bypass (SUB) 
Within the last few years, SUB devices had been introduced as a palliative treatment for the 
management of feline ureterolithiasis and, although reports of the use and outcome of cats with 
SUB devices are limited in the veterinary literature, it appears to improve the survival rate as 
well as the complications rate (Berent, Weisse, Bagley & Lamb, 2018). Given that, SUB 
devices are preferred for the management of ureterolithiasis in cats (Deroy et al., 2018; Milligan 
& Berent, 2019).  
The SUB can be considered for the treatment of all causes of ureteral obstruction. An 
appropriate practical training with this device is essential before using it on an animal, in order 
to optimize the cat’s outcome (Lulich et al., 2016; Berent & Weisse, 2018). 
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2.5.2 Surgical procedure  
A SUB device (Norfolk Vet Products®) consists in a locking-loop pigtail nephrostomy catheter 
attached via a shunting port to a multi-fenestrated locking-loop cystostomy catheter, as showed 
in figure 10 (Berent & Weisse, 2018).   
 
 
 
 
 
 
 
 
 
 
 
With the aid of fluoroscopy, the nephrostomy catheter is placed by use of the modified 
Seldinger technique. First of all, a ventral midline laparotomy is performed to expose the 
urinary bladder apex and the affected kidney; and the peri-renal fat is gently dissected off the 
caudal pole of the kidney, exposing a 1 to 2 cm region of the renal capsule. A 18 G over-the-
needle catheter is used to puncture the renal pelvis at the caudal pole of the kidney (figure 11). 
A urine sample is then obtained for bacterial culture and an iohexol diluted with equal volume 
of sterile saline solution is injected into the renal pelvis to perform an antegrade pyelography. 
Under fluoroscopy guidance, a 0.035’’ J-tip guidewire is advanced through the catheter and 
coiled inside the renal pelvis with the utmost attention to avoid perforation. Once 1 to 2 loops 
are made within the renal pelvis, the catheter is removed while the guide wire is carefully 
secured within the renal pelvis and then, the locking-loop pigtail nephrostomy catheter is 
advanced over the wire (figure 12). After it enters the renal pelvis, the guidewire is removed 
and the locking string is pulled, creating a pigtail inside the renal pelvis to prevent the catheter 
dislodgement.  
 
 
 
 
 
Figure 10. The SUB device put together outside of the patient (adapted from Berent & 
Weisse, 2018). 
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The black radiopaque marker of the nephrostomy catheter marks the last fenestration of the 
catheter, which should always be within the renal pelvis. Fluoroscopy should aid to ensure this, 
as well as the appropriate draining and filling of the renal pelvis and absence of leaking. 
Afterwards, the dacron cuff is gently advanced down the nephrostomy catheter and sterile glue 
is applied between the dacron puff and the renal capsule in order to keep the catheter secure in 
the renal pelvis and to prevent leakage or dislodgement (figure 13) (Berent & Weisse, 2018; 
Berent et al., 2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: Left frame: 18G catheter (black arrow) puncturing the renal pelvis through the caudal pole 
of the kidney. Right frame: the nephrostomy catheter is advanced over the wire. 
Figure 11 and figure 12. Nephrostomy access into the kidney (adapted from Berent & 
Weisse, 2018 and original, kindly provided by the CHV-Frégis, respetively). 
Figure 13. Application of sterile glue to secure the catheter (original, kindly provided by 
the CHV-Frégis). 
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Guidelines for the SUB placement by Berent and Weisse (2018) recommend a different 
approach when the renal pelvis is < 8 mm, since the authors have found it easier and safer to 
place the nephrostomy catheter down the ureter instead of the renal pelvis. A 22 G IV catheter 
is inserted in the caudolateral aspect of the kidney angled toward the ureter. After confirmation 
of the direction of the catheter with fluoroscopy, a 0.018’’ angle-tipped guide wire is advanced 
through the catheter and then this latter was removed over the wire. Afterwards, a 18 G catheter 
is advanced over the wire, which is removed and substituted with a 0.035’’ angle-tipped guide 
wire and a nephrostomy catheter without the hollow cannula is advanced after the removal of 
the 18 G catheter. The nephrostomy catheter is modified previously: the locking string is cut to 
create a straight “ureterostomy” catheter. The rest of the procedure is performed as described 
above.  
For the cystostomy catheter placement, a purse-string suture is placed (figure 14) at the apex of 
the urinary bladder and a stab incision is made in the center. In the case of a bilateral SUB 
placement, in order to both catheter sit as close as possible to the apex, each catheter should be 
placed just off the midline. The cystostomy catheter is then advanced into the urinary bladder 
until the radiopaque marker is within the lumen and a pigtail is formed. Afterwards, the purse-
string suture is secured around the catheter and the dacron puff is suture and glued to the serosal 
surface of the urinary bladder. The utmost care should be taken to ensure that the catheter is not 
too far into the urinary bladder since this could be irritating and cause signs of dysuria in the 
cat. Following that, saline solution is infused through the catheter to ensure the absence of 
leakage (Berent & Weisse, 2018; Berent et al., 2018).  
Finally, skin and subcutaneous tissues, immediately lateral to the ventral incision, on the 
ipsilateral side, are dissected down to the abdominal musculature. Both catheters are passed 
through the body wall and the shunting port is placed approximately hallway between the 
xiphoid and the pubis (figure 15). Once all parts positioned, a blue boot is placed over the 
catheters and the nephrostomy catheter is attached to the caudal aspect of the shunting port 
whereas the cystostomy catheter is connected to the cranial aspect, which maintain a gentle 
loop of the device and prevent kinks. Once the device is closed, it is leak tested to confirm the 
absence of leakage and afterwards, the shunting port is sutured to the ventral body wall. Topical 
bupivacaine is recommend in the subcutaneous pocket, around the shunting port. After the end 
of the surgery, fluoroscopy is performed to ensure that the catheters and the radiopaque markers 
are well situated in the renal pelvis and urinary bladder, with an appropriate filling of the renal 
pelvis and to confirm the absence of kinks and leakage (Berent & Weisse, 2018; Berent et al., 
2018). 
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However, since access to fluoroscopy is sometimes limited, some surgeons are reporting 
effective and safe placement of the SUB device without fluoroscopy with no major difficulties 
or complications compared with the fluoroscopic guidance, demonstrating that a fluoroscopy is 
not essential in all cases (Deroy et al., 2017; Livet et al., 2017). The limitations of this technique 
are mostly related with the implantation of the nephrostomy catheter in cats with a minor 
pyelectasia and in cats with concurrent nephroliths, which reveals to be challenging/impossible 
without fluoroscopy (Livet et al., 2017). 
2.5.3 Postoperative management 
All animals should be carefully monitored during the postoperative period, with especial control 
of hydration status, urine output, anemia, serum concentrations of creatinine, BUN, phosphorus 
and potassium, among other biochemical parameters (Berent et al., 2018). An adequate 
postoperative analgesia and antimicrobial treatment is also important (Livet et al., 2017; Berent 
et al., 2018). There is evidence that cats that did not received antibiotics postoperatively had a 
significantly higher risk for the development of a positive urine culture after hospital discharge, 
(Berent et al., 2018; Kopecny, Palm, Drobatz, Balsa & Culp, 2019). Prior to hospital discharge, 
a flush of the SUB device is recommend, in order to ensure the absence of an occlusion of the 
device (Berent & Weisse, 2018; Berent et al., 2018). 
Legend: Left frame: a purse string suture is made at the apex of the bladder. Right frame: the shunting port 
is placed approximately hallway between the xiphoid and the pubis.  
Figure 14 and figure 15. Placing the cystotomy catheter and shunting port (adapted from Berent 
& Weise, 2018 and original, kindly provided by the CHV-Frégis, respectively).  
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2.5.4 Follow-up and flush of the SUB device 
A regular follow-up of the animal is of major importance for an adequate control of the SUB 
device, the renal function and the clinical condition of the cat. Therefore, a serum biochemical 
profile, complete blood count, urinalysis, urine bacterial culture, abdominal ultrasonography 
with flushing of the SUB device and systolic blood pressure should be measured every 1, 3, 6, 
9 and 12 months after the surgery and then every 3 to 6 months (Livet et al., 2017; Berent & 
Weisse, 2018; Berent et al., 2018). Flushing of the SUB device can be performed more regularly 
in animals with higher risk for device encrustation or for a urinary tract infection (Berent et al., 
2018). 
The SUB flushing is typically performed in a sterile manner using ultrasound guidance with 
minimal restraint of the animal. The fur over the shunting port is clipped and the skin is 
aseptically prepared. With a Huber needle in a perpendicular manner, a urine sample is obtained 
and submitted for urinalysis and bacterial culture. Afterwards, the device is flushed and the 
renal pelvis is monitored to confirm its distension and to avoid an overfilling of the renal pelvis. 
Then, the same volume of fluid is aspired and this procedure is repeated for the urinary bladder 
(Berent & Weisse, 2018; Berent et al., 2018). The SUB device may also be flushed under 
fluoroscopic guidance, in which the fluid is mixed with the contrast (Berent & Weisse, 2018).  
 It is recommended to infuse tetrasodium ethylenediaminetetraacetic acid (tetra-EDTA) for the 
flushing of the device, since this substance helps to prevent the formation of biofilm, 
mineralization and occlusion of the device (Berent & Weisse, 2018). This substance functions 
also as an anticoagulant and antimicrobial agent, therefore, protocols for flushing of SUB 
devices with mineralization and infection are available (Norfolk Vet Products, 2018). 
2.5.4 Complications  
Since the introduction of the SUB device, both short-term and long-term complications have 
improved for cats with ureterolithiasis (Milligan & Berent, 2019).  Many of the complications 
reported were technical and can be avoided with a previous proper training (Berent & Weisse, 
2018).  
Intraoperative complications were not common, reported in approximately 0% to 7% of cats, 
which included leakage of urine from the SUB device, occlusion of the device with blood clot, 
kinking of the catheters and iatrogenic renal hemorrhage (Horowitz et al., 2013; Deroy et al., 
2017; Berent et al., 2018). Livet et al. (2017) reported an intraoperative complications rate of 
15% in 13 cats. One of the two complications in this study was caused by a misplacement of 
the nephrostomy catheter, possibly secondary to an absence of fluoroscopic guidance. 
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Nevertheless, Deroy et al. (2017) also did not use fluoroscopy in the SUB surgeries of 23 cats 
and did not report any intraoperative complications.  
Urine leakage from the SUB device or from the urinary tract resulted, in the majority of times, 
from technical errors during the surgery associated with the cut of the locking strings not close 
enough of the catheter (figure 16). Therefore, urine leakage was frequently founded at the 
junction of the shunting port and the catheters, where the locking strings were secured (Berent 
& Weisse, 2018; Berent et al., 2018). This complication was only described in the intraoperative 
and perioperative period, in approximately 0 to 3% of cats or 3.5% of SUB devices (Deroy et 
al., 2017; Luca et al., 2017; Berent et al., 2018). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kinking of the SUB device was also a complication described early after the surgery and, most 
frequently, resulted also from a technical error during the surgery (figures 17 and 18). To avoid 
this, it is important to connect the cystostomy catheter to the cranial aspect of the shunting port 
and the nephrostomy catheter to the caudal aspect, as well as place the shunting port hallway 
between the xiphoid and the pubis, in which a rule may useful for accomplish this latter (Berent 
& Weisse, 2018; Berent et al., 2018). Approximately 5% of devices presented this complication 
(Berent et al., 2018). 
Legend: Leakage of contrast (black arrow) seen at the cranial pole of the kidney. This was due to 
inadvertent guide wire puncture of  the renal pelvis which was of no clinical consequence. 
Figure 16. Fluoroscopic image showing leakage of the contrast from the kidney (adapted 
from Berent & Weisse, 2018). 
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Occlusion of the SUB device was reported in approximately 5 to 10% of cats or 8 to 24% of 
SUB devices (Deroy et al., 2017; Livet et al., 2017; Luca et al., 2017; Berent et al., 2018).  
Blood clot or mineralization were the main causes of occlusion of the SUB device, in which an 
obstruction caused by blood clots was usually identified within the first month after surgery 
while mineralization was almost always described in the long-term period. When a blood clot 
was present, flushing of the SUB device with tissue plasminogen activator resolved the 
occlusion in 36% of cases (figures 19 e 20) (Berent et al., 2018). Therefore, the use of this 
substance appears to be promising since it may avoid more invasive means of blood clot 
dissolution or extraction and prevent a surgery for device exchange (Hoii & Lemetayer, 2017). 
A case of a cat with perioperative occlusion of the SUB device secondary to a severe 
pyonephrosis was recently reported by Vedrine (2017). Repetitive flushing of the device 
successfully resolved the obstruction, therefore it may be considered an effective treatment for 
these cases.  
 
 
 
 
 
 
Figure 17 and figure 18. Fluoroscopic images of kinking of the SUB device (adapted 
from Berent & Weisse, 2018).  
Legend: kinked SUB devices (red arrow). 
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Mineralization of the SUB device was also a long-term complication identified in 4% of cats 
by Deroy et al. (2017) and in 24.5% of devices by Berent et al. (2017). Approximately half of 
the cases required a device exchange (figure 21). However, the other half did not need any 
further treatment since the affected ureters had become patent again. There is evidence that, 
once an ureterolithiasis is managed and the ureter is decompressed, a decrease in the luminal 
edema and hydrostatic pressure occur and, in some cases, the ureterolith can pass (Berent et al., 
2018). Yet, the passage of ureteroliths leads to an increased risk for urethral obstruction with 
those ureteroliths, which was reported in one cat by Deroy et al. (2017) and another cat by Livet 
et al. (2017). With the use of tetra-EDTA solution for flushing SUB devices, the rate of 
mineralization has been declining, and a specific protocol is available as an attempt to minimize 
the mineralization incrusted in the device (Norfolk Vet Products, 2018). Flushing of the SUB 
with this solution is especially important in cats with a higher risk of encrustation of the device, 
such as in cats with hypercalcemia, since a postoperative ionized hypercalcemia was 
significantly associated with postoperative occlusion from mineralization or in cats with a 
previous history of device mineralization (Berent & Weisse, 2018; Berent et al., 2018). 
 
 
 
 
 
Legend: Left frame: important hydronephrosis of the kidney with a blood clot obstructing the SUB 
device. Multiple flush with tissue plasminogen activator resolved the obstruction. Right frame: 24 hours 
after the device flush with tissue plasminogen activator, the renal pelvis and blood clot reduced their 
dimensions. 
Figure 19 and figure 20. Abdominal ultrasonographies showing the diminution of a blood 
clot in the renal pelvis (original, kindly provided by the CHV-Frégis). 
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Signs of dysuria were present in approximately 4% to 38% of cats but its presence did not seem 
to adversely affect the quality of life of cats, according to owners’ opinion (Deroy et al., 2017; 
Livet et al., 2017; Luca et al., 2017; Berent et al., 2018). Compared to ureteral stenting, 
placement of a SUB device have lower rates of dysuria, which may be a result of the location 
of the device, since both devices are made of the same material. While the cystotomy catheter 
of the SUB device is placed at the apex of the urinary bladder, the ureteral stent may cause an 
irritation in the urothelium, given that the curl is positioned at the trigonal region and cranial to 
the proximal portion of the urethra (Berent et al., 2014; Deroy et al., 2017; Livet et al., 2017; 
Berent et al., 2018). Furthermore, when a ureteral stent was replaced by a SUB, in cats 
presenting refractory signs of dysuria, an immediate resolution of this sign was noted (Deroy et 
al., 2017; Berent el al.,2018).  The occurrence of dysuria after the placement of a SUB device 
was significantly associated with a previous existence of signs of dysuria before the surgery 
(Berent et al.,2018).   
A positive urine bacterial culture was documented in 24 to 31% of cats and the most common 
microorganism isolated consisted of Enterococcus spp (Livet et al., 2017; Berent et al., 2018; 
Kopecny et al., 2019). The importance of this bacteria in cats with urinary implants lies in both 
its mechanisms for antimicrobial resistance as well as its capacity to the formation of biofilms 
on the devices, making the infection clearance challenging (Kopecny et al., 2019). The most 
recent guidelines from the ISCAID indicate that, for the treatment of a sporadic bacterial 
cystitis, amoxicillin is a reasonable first choice antibiotic, likewise trimethoprim-sulfonamides. 
Legend: Asterisk: nephrostomy catheter. Dagger: cystotomy catheter.  
Figure 21. Retrieved SUB devices from a cat with an obstruction due to mineralization 
(adapted from Deroy et al., 2017). 
38 
 
When these are not available or appropriate, nitrofurantoin, fluoroquinolones and 3rd 
generation cephalosporins may be considered (even if it is controversial due to antibioresistance 
policy). The same guidelines suggest that treating a subclinical bacteriuria with antimicrobials 
is rarely indicated and discouraged. When it is uncertain if clinical signs are attributed to 
cystitis, antimicrobials may be used during a short course (3 to 5 days). These recommendations 
are also valid for multidrug resistant bacteria, since these organisms are not more likely to cause 
disease that their susceptible counterparts. Moreover, anecdotal information suggests that when 
the treatment is withheld, multidrug resistant organisms may, sometimes, be replaced with 
susceptible organisms. Currently, there is no evidence that adjunctive treatment, such as 
cranberry extracts or probiotics, are effective for the prevention of subclinical bacteriuria, but 
it is not contraindicated to use supplements that are known to be safe (Weese et al., 2019).  
Although currently, there is no consensus regarding the classification of the resistance profile 
of bacteria in the veterinary medicine, the important increase of antimicrobial resistance in the 
recent years, suggests that further categorization is needed in order to communicate the true 
clinical impact of antimicrobial resistance (Magiorakos et al., 2012; Sweeney, Lubbers, 
Schwarz & Watts, 2018). As already stated, there is evidence that cats that did not receive 
antibiotics postoperatively had a significantly higher risk for the development of a positive urine 
culture after hospital discharge, (Berent et al., 2018; Kopecny et al., 2019). Moreover, cats that 
had a urinary tract infection before the surgery were more likely to develop another urinary 
tract infection after the SUB device placement (Berent et al., 2018). For these cats, with a higher 
risk for infection, flushing of the SUB with the tetra-EDTA solution is especially important to 
help the infection’s clearance (Berent & Weisse, 2018; Berent et al., 2018; Norfolk Vet 
Products, 2018). 
Anemia was identified in approximately 15 % of cats, and this may be because of an underlying 
CKD, excessive blood sampling during previous hospitalizations or due to inflammation 
(Shipov & Segev, 2013; Livet et al., 2017). 
2.5.5 Outcome and Prognosis  
Results of a recent study including 134 cats showed that for all cats the SUB device was 
successfully placed, there was an immediate renal decompression (Berent et al., 2018). The 
placement of the SUB device was associated with an overall survival time of 827 days and an 
overall mortality rate of 15% to 28% (Deroy et al., 2017; Livet et al., 2017; Berent et al., 2018).  
There is no record of mortality of cats during the surgery excepting for 2 cats who died during 
the anesthesia recovery period. The mortality rate associated with the placement of a SUB 
device was approximately between 5 and 15% in the perioperative period,  3% in the short-term 
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period (between 7 and 30 days after the procedure) and 11% in the long-term period (>30 days 
after the procedure) (Horowitz et al., 2013; Deroy et al., Livet et al., 2017; Berent et al., 2018). 
Berent et al. (2018) reported that the serum creatinine concentration and IRIS stage 3 months 
after the device placement were the only postoperative factors significantly associated with the 
overall survival time in which cats with IRIS stage I and II had a significantly increased overall 
survival. Moreover, Horowitz et al. (2013) had the same results, with the addition of creatinine 
before discharge and IRIS stage at 6 months were also associated with the overall survival time.  
When it comes to preoperative factors, a previous history of CKD, a history of weight loss and 
the development of fluid overload prior to the surgery were the only preoperative factors 
significantly associated with the overall survival time (Berent et al., 2018).  
Despite the existence of few investigations and research works regarding this subject, results 
from recent studies suggested that placement of the SUB device is a viable alternative in cats 
with ureteroliths and, overall, owners rated a high quality of life of theirs cats, following the 
placement of the device (Livet et al., 2017; Berent et al., 2018). This suggests an overall good 
prognosis, but the outcome is largely determined by the progression and severity of the 
underlying CKD after the decompression of the kidney. Cats with a more advanced CKD 
therefore have a more guarded prognosis (Horowitz et al., 2013; Deroy et al., 2017; Berent et 
al., 2018). 
Results and outcome should, however, be interpreted and analyzed in a critical manner since 
the longest SUB device has been indwelling for 8 years in a cat, therefore, outcome beyond this 
point are unable to be ascertained (Berent & Weisse, 2018). 
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3. MATERIAL AND METHODS   
3.1 Introduction and Objectives 
The ureteral obstruction is becoming more frequent, especially in cats, with the most common 
cause being an intraluminal obstruction secondary to ureterolithiasis. They require immediate 
care, in order to prevent a decrease in renal function, regardless of whether the obstruction is 
partial or complete (Lulich et al., 2016). Renal decompression in cats can be realized 
traditionally but given the potential complications and mortality associated with these 
procedures, alternatives have been investigated for animals over the past years. Veterinary 
Interventional Medicine research has been looking for a less invasive technique that leads to an 
immediate renal decompression and stabilization of the azotemia while simultaneously prevent 
postoperative complications (Berent, 2011; Milligan & Berent, 2019).  
Recently, sucbuctaneous ureteral bypass (SUB) placement has been considered for the 
treatment of the main causes of ureteral obstruction. Although SUB devices appear to improve 
the survival rate and outcome in cats with ureteral obstruction, reports about their complications 
and outcome are limited in the veterinary literature (Lulich et al., 2016; Berent, et al., 2018).  
This study aims to evaluate the outcome of cats with SUB devices used for the treatment of 
ureteral obstruction, to describe short-term and long-term complications associated with this 
surgical procedure as well as to identify factors that may have an influence in the occurrence of 
these complications. 
3.2 Experimental design 
For this study, case records of cats that underwent a SUB placement in the Centre Hospitalier 
Vétérinaire Fregis, France, between February 2014 and January 2019 were retrospectively 
identified by use of a computerized medical database search with the coding term 
“subcutaneous ureteral bypass”.  
The study variables regarding the population’s characterization and preoperative information 
that were recorded included: age, sex, reproductive status, race, clinical signs, previous history 
of chronic kidney disease (CKD) or other concomitant diseases, suspected ureteral 
obstruction’s cause, localization of uroliths, if a medical management was attempted, 
measurements of the transverse plane of the renal pelvis and ureteral dilatation. Data concerning 
preoperative laboratorial findings were also collected: serum concentrations of BUN and 
creatinine at admission, presence of serum potassium concentration disorders, anemia and urine 
specific gravity (USG) at admission. 
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In the postoperative period, the information assembled consisted on: placement of unilateral or 
bilateral SUB device, measurement of the renal pelvis after surgery, serum concentrations of 
BUN and creatinine (24 hours after the surgery, at the hospital discharge and 7 days after the 
surgery), presence of serum potassium concentration disorders, presence of anemia, duration of 
hospitalization and occurrence of complications. Specific complications that were assessed 
consisted on: eventual SUB device occlusion, urine leakage from the device or urinary tract, 
mineralization of the device, bacteriuria, anemia, clinical signs of dysuria and deaths of a 
suspected renal cause. Then, complications were classified in major complications and minor 
complications. Major complications included device occlusion, urine leakage and 
mineralization of the device whereas minor complications included a positive urine culture, 
anemia and signs of dysuria. 
Complications associated with placement of the SUB device were assessed in the intraoperative 
period (from the time of anesthetic induction until full recovery from the anesthesia), in the 
perioperative period (from full recovery to 7 days after surgery) and in the postoperative period 
divided into a short term (1, 3, and 6 months) and a long term (1, 2, 3 and 4 years after surgery) 
whenever possible. In the postoperative period, the serum concentration of urea and creatinine, 
as well as the measurement of the renal pelvis, were registered at these times. 
Whenever a bacterial culture was positive, an antimicrobial susceptibility testing (AST) was 
performed. The urine was seeded in chromogenic agar (Biomérieux) with a 10 microlitre 
inoculation loop. The method utilized in the AST was the disk diffusion test, with 
concentrations of antibiotics according with the Veterinary Antibiotic Committee of the French 
Society of Microbiology (CASFM). The break points were also automated according the 
Veterinary CASFM (Comité de l’antibiogramme de la Société Française de Microbiologie 
Vétérinaire, 2018; Comité de l’antibiogramme de la Société Française de Microbiologie, 
2019). Afterwards, if the bacteria had a resistance profile, it was classified, based in the standard 
definitions of an international expert proposal by Magiorakos et al. (2012) for human medicine. 
However, considering that many drugs are not authorized in the French country, fewer 
antibiotics are tested in the AST comparing in other countries. Bacteria with a low level of 
antimicrobial resistance was considered when non-susceptibility to at least one agent in three 
or more antimicrobial categories was presented; a medium level of antimicrobial resistance was 
considered for non-susceptibility of the bacteria to at least one agent in all but two or fewer 
antimicrobial categories and a high level of antimicrobial resistance was given for bacteria with 
a non-susceptibility to all agents in all antimicrobial categories. 
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Dysuria is typically manifested as pollakiuria and/or stranguria (Berent et al., 2014; DiBartola, 
S. P. & Westropp, J. L., 2014), therefore, these clinical signs are included in the variable signs 
of dysuria.   
From referred cats, the information provided by the primary veterinarian, such as history and 
blood and urine analysis, were included in the present study.  
The duration of hospitalization was defined as the time between the day of the surgery until the 
day of the hospital discharge. When owners requested a hospital transfer to their primary 
veterinary hospital, the remaining days in their facilities were also considered, if the information 
was available.   
Criteria for safe discharge from the hospital included good clinical condition and appetite as 
well as an important decrease in the serum creatinine concentration. Recommendations for 
stimulation of the water consummation and implementation of a renal diet were suggest to 
owners, at the hospital discharge.  
3.4 Routine hospital procedures concerning cats undergoing SUB placement 
Routinely, before surgery, cats undergo abdominal ultrasonography performed by board-
certified diagnostic imaging specialists or residents under their supervision. The ureteral 
obstruction was diagnosed based on the identification of a hydronephrosis with an associated 
hydroureter and/or the identification of ureteroliths.  
The medical management consists essentially in an aggressive intravenous fluid therapy 
combined with analgesia. Frequently, an osmotic diuretic, typically furosemide, can also be 
administered, according to the clinician’s decision. 
In the preoperative period, the drugs routinely administered to cats are: morphine (0.2 mg/kg, 
slow IV) and midazolam (0.2 mg/kg, IV). General anesthesia is induced with propofol and 
maintained with volatile isoflurane. Surgery is performed by board-certified surgeons and third 
and second-year surgical residents, under their supervision. An open surgical approach without 
the aid of fluoroscopy is commonly performed in all cats, as well as a complete abdominal 
exploration, and any abnormalities identified were noted. Affected ureters are located and the 
location of the obstruction is noted, when identified.   
The SUB device (Norfolk Vet Products®) includes a 6.5F locking-loop catheter and a 
multifenestrated 7F catheter, placed as a nephrostomy and cystostomy tube, respectively. A 
urine sample is routinely obtained intraoperatively for a bacterial culture and an antimicrobial 
susceptibility testing.  
Postoperative radiographic study is performed in order to ensure that the SUB device is 
appropriately placed correctly in the kidney and bladder and there is no urine leakage or catheter 
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kinking by contrast medium injection. A Huber needle (Norfolk Vet Products®) is used to 
inject, slowly through the shunting port, 3 mL of diluted (1:1) iohexol, followed by 3 mL of 
sterile saline (0.95% NaCl) solution to flush the contrast medium from the catheter.  
For the postoperative pain control, all cats usually receive analgesia with buprenorphine, which 
is typically continued postoperatively. A combination of fentanyl, lidocaine and ketamine can 
also elected when severe signs of discomfort and pain are demonstrated by the cat. An 
antimicrobial therapy is instituted with a general duration of 4 to 8 weeks and multiple urine 
cultures are performed during and after the treatment.  
Concerning postoperative controls, routine physical exams are performed 2 to 3 times a day. 
Serum creatinine and urea concentrations are monitored 24 to 48 hours post surgery and every 
24 to 48 hours during hospitalization until stabilization of these parameters. If the parameters 
are not improving, a recheck ultrasound is routinely performed. One month after the surgery, a 
flush of the SUB device is recommend, as well as urine culture, urine protein-to-
creatinine ratio, measurement of the phosphorus, ionized calcium, creatinine and urea 
concentration. Three months after the surgery, these latter parameters are monitored and a flush 
of the device is performed. It is suggested to owners to repeat the flush procedure, every 3 to 4 
months. The blood pressure measurement is also routinely performed at the time of the control, 
when the clinician considered necessary. 
3.6 Statistical analysis 
Analysis was performed in order to determine whether preoperative and postoperative factors 
were associated with the occurrence of major complications and duration of the hospitalization. 
For qualitative variables, frequency analysis was performed with the χ2 or Fisher exact test, 
when appropriate. The quantitative variables were analyzed with the Wilcoxon signed-rank test. 
Numerical data were summarized as median and range.  
The risk over time of major complications and the survival curve were determined with the 
Kaplan-Meier curve function. When the complication or death had not yet occurred, time to 
last follow-up was used to censor records. 
In order to assess if a correlation was present between the serum creatinine concentration and 
the days passed in hospitalization, a Spearman’s rank correlation test was performed, as well 
for the urea serum concentration.  
Data obtained in the current study were stored in a Microsoft Excel 2016® datasheet and all 
statistical analysis were performed using The R Project for Statistical Computing version 3.6.0. 
Values of p < 0.05 were considered significant.  
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4. RESULTS 
4.1 Characterization of the population  
129 cats were included in this study. From them, 52% (67/129) were females and 48% (62/129) 
were males. 83% (107/129) were castrated cats whereas 17% (22/129) were sexually intact cats. 
Median age at the time of SUB device placement was 7.7 years (range 2 to 17 years). 
There were 62% (80/129) domestic shorthairs, 12% (16/129) Birman, 5% (6/129) British 
Shorthair, 4% (5/129) Norwegian Forest Cat, 3% (4/129) Maine Coon and 14% (18/129) of 
other breeds. Other breeds included Chartreux (3), Persian (3), Bengal (2), Abyssinian (1), 
Angora (1), Balinese (1), Korat (1), Oriental Shorthair (1), Persian Chinchilla (1), Ragdoll (1), 
Russian Blue (1), Siamese (1) and Somali (1).  
4.2 History and clinical findings at hospital admission  
At hospital admission, the most common clinical signs included anorexia or dysorexia (61% 
[79/129] cats), lethargy  (48% [62/129]), vomiting (40% [51/129]), weight loss (25% [32/129]), 
polyuria and/or polydipsia (16% [20/129]), signs of dysuria (9% [12/129]), oliguria or anuria 
(5% [7/129]), hematuria (3% [4/129]) and abdominal pain (3% [4/129]). 
Laboratory testing performed at the initial evaluation revealed an anemia in 8% (10) of cats, 
with a median value of hematocrit of 19.6 % (range 14% to 24%; reference interval 25 to 45%), 
in these cats. The urine specific gravity was measure in 55 cats demonstrating a median value 
of 1,020 (range 1,005 to 1,050; reference interval > 1,035). 
Median serum urea concentration was 227.47 mg/dL (range 34 to 569 mg/dL; reference interval 
30 to 60 mg/dL) while median serum creatinine concentration was 8.57 mg/dL (range 1.5 to 
27.2 mg/dL; reference interval 0.6 to 1.6 mg/dL).   
Regarding electrolyte disorders, 19% (25; reference interval 3.5 to 4.8 mmol/L) of cats had a 
hyperkalemia while 4% (5) had a hypokalemia.  
Before hospital admission, 13% (18) of cats were already being followed for a history of CKD. 
Other concomitant diseases were present in 12% (15) of admitted cats and included 
hypertrophic cardiomyopathy (5) and myxomatous mitral valve degeneration (2) as the most 
frequent concomitant diseases registered.  
From these 129 cats, 5% (7/129) had previous surgeries of the urinary tract due to former 
ureteral obstructions. Ureteral stents were placed in 5 cats, in which 1 of them also had a 
cystotomy and ureterotomy performed and one had a cystotomy realized. For the other 2 cats, 
one had a nephrectomy and one an ureterotomy performed before their SUB placement.  
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4.3 Diagnostic imaging findings 
Information about preoperative abdominal was available for 97% (125/129) of cats. 
Ureterolithiasis was the most common cause of ureteral obstruction and, therefore, ureteroliths 
were identified in 98% (122/125) of cats, in which 3 cats had an ureteral stent that obstructed. 
Other causes of ureteral were ureteral strictures, which were identified in 2% (2/122) cats and 
1 cat (1/122) had recurrent cystitis caused by an ureteral stent. 
The ureteral obstruction was found in the proximal portion of the ureter (proximal third of the 
ureter) in 49% (63) of ureters, in the mid portion (mid third of the ureter) in 24% (31), in the 
distal portion (distal third of the ureter) in 36% (46) and at the ureterovesicular junction in 9% 
(12) of ureters. 
Hydroureter was found in 57% (77/135) of ureters, with a median ureteral diameter of 3.3 mm 
(range, 1 to 12 mm; reference interval < 0.4 mm). Hydronephrosis was also detected in 89% 
(150/168) of ureters, with a median renal pelvic diameter of 11 mm (range, 1.7 to 50 mm; 
reference interval < 1.6 mm), determined in the transverse plane. 
Concomitant nephroliths were visualized in 32% (41) of cats, cystic calculi were present in 9% 
(11) of cats and 2% (3) of them also had a urethral lithiasis. 
4.4 Ureteral obstruction management  
There are records of a medical treatment attempted for 61% (79) of cats, before the SUB device 
placement. 65% (84) of cats underwent a unilateral SUB device placement and 35% (45) 
underwent a bilateral SUB device placement, for a total of 174 obstructed ureters. In the 84 cats 
in which a SUB device was placed unilaterally, 56% (47) had an obstruction in the right ureter 
and 44% (37) in the left ureter.  
Concomitantly to the SUB device placement, other interventions were performed at the same 
surgical time in 6% (8/129) cats: a cystotomy in 3 cats for cystic calculi removal, nephrectomy 
of the contralateral kidney in 2 cats, urethrotomy in 2 cats and, in one cat, a ureteral stent in the 
contralateral ureter.    
In one cat with a renal pelvic diameter of 3 mm, the implantation of the nephrostomy catheter 
in this minor pyelectasia showed to be challenging so, since fluoroscopy was not available, 
ultrasonography was used during the surgery in order to assist the nephrostomy placement into 
the renal pelvis.  
4.5 Postoperative data 
Median urea and serum creatinine concentrations 24 hours after SUB device placement were 
166.2 mg/dL (range 23 to 434 mg/dL) and 4.6 mg/dL (range 0.5 to 17.8 mg/dL), respectively.  
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Median hospitalization time was 5 days (range 1 to 14 days) and approximately 12% (16) of 
cats died prior to hospital discharge.  
Median serum creatinine concentration recorded before hospital discharge was 2.5 mg/dL 
(range 0.9 to 13.2 mg/dL) and median serum urea concentration was 95.3 mg/dL (range 20 to 
355 mg/dL). 
4.6 Complications 
4.6.1 Intraoperative complications 
Complications occurred during the surgery in 3% (4/129) of cats. Two cats suffered from 
iatrogenic renal hematomas during the nephrostomy catheter’s implantation. One of these cats 
had a degradation of its clinical condition the days subsequent the surgery as well as a 
worsening azotemia and aggravation of the renal lesions, which leaded to a consented decision 
of euthanasia, 2 weeks after the surgery. In 1 cat, the implantation of the nephrostomy catheter 
resulted in an important hemorrhage and sub capsular kidney urine leakage so, a reimplantation 
of this catheter had to be done. The last cat also had a urine leakage but from the nephrostomy 
catheter. Since this leakage could not be solved, another nephrostomy catheter was placed and 
connected to the cystotomy catheter with a male-male adaptor, because of the prolonged 
surgery’s time (figure 22). Despite all of that, no deaths were described during the surgery time.  
 
 
 
 
 
 
 
 
 
Figure 22. Dorsoventral view radiograph of a cat with a male-male adaptor (original, kindly 
provided by the CHV-Frégis). 
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4.6.2 Perioperative complications 
Information on complications occurring since full recovery from the anesthesia to 7 days after 
surgery was available for 116 of 129 cats. Documented complications included occlusion of the 
SUB device system in 10% (12/116) of cats, leakage from the SUB device in 3% (4/116) of 
cats, a positive urine culture in 9% (10/116) of cats, signs of dysuria in 10% (12/116) of cats 
and anemia in 14% (16/116) of cats. In the 4 cases of leakage, a second surgery was needed for 
the replacement or reconditioning of the SUB device. In the 16 cats with anemia, the median 
value of the hematocrit was 17.3 % (range 10% to 24%).  
During this period, a mortality rate of approximately 14% (16/116) was identified. 
4.6.3 Short-term and long-term complications 
Complications were characterized at 1, 3 and 6 months and 1, 2, 3 and 4 years after the SUB 
device placement, when information was available. 
4.6.3.1 Complications 1 month after SUB device placement 
Information on complications that occurred 1 month after the placement of the SUB device was 
available for 61 (47%) cats. The most common complications detected were: occlusion of the 
SUB device system in 2% (1/61) of cats, leakage from the SUB device in 2% (1/61) of cats, an 
positive urine culture in 18% (11/61) of cats, signs of dysuria in 18% (11/61) of cats and an 
anemia in 7% (4/61, median value of hematocrit of 18%) of cats and mineralization of the 
device in 2% (1/61) of cats. One cat had a second surgery performed for the reconditioning of 
the SUB device following a leakage of urine from the device.  
During this period, the mortality rate was approximately of 3% (2/61).  
4.6.3.2 Complications 3 months after SUB device placement 
Three months after the surgery, information was available for 52 from 129 (40%) cats. From 
these, 8% of cats (4/52) had evidence of occlusion of the SUB device, 13% (7/52) had a positive 
urine culture and 8% (4/52) of cats presented signs of dysuria. Anemia was not observe in any 
of the cats.   
One additional cat was euthanized, which conferred a mortality rate, between 1 month and 3 
months post surgery, of 2%. 
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4.6.3.3 Complications 6 months after SUB device placement 
The most common complications identified 6 months after surgery, in the 49 (38%) animals 
where data were available, were a positive urine culture in 20% (10/49) of cats and evidence of 
dysuria’s signs in 16% (8/49) of cats. More severe complications were present in a fewer 
number of animals, with an occlusion of the SUB device in 10% (5/49) of cats, mineralization 
of the device in 2% (1/49) of cats and leakage of urine from the device in 2% (1/49) of cats. 
Anemia was only observed in 1 cat which had a hematocrit of 19%.  
A second surgery was needed for 4 cats (8%) for replacement or reconditioning of the SUB 
device due to urine leakage from the device in 1 (2%) cat and because of an obstruction due to 
mineralization of the device in 3 (6%) cats (figure 23).  
There are record of 1 from the total of 49 cats was euthanized, which confer a mortality rate of 
2% between 3 and 6 months after SUB device placement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Legend: The absence of contrast revealed an occlusion in the nephrostomy catheter. The cat had 
a second surgery for the replacement of this catheter. 
Figure 23. Dorsoventral view radiograph showing the absence contrast in the renal pelvis 
(original, kindly provided by the CHV-Frégis). 
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4.6.3.3 Complications 1 year after SUB device placement 
Fifty one (40%) of 129 cats had available information on complications occurring 1 year after 
the surgery. Documented complications included occlusion of the SUB device system in 20% 
(10/51) of cats, mineralization of the device in 6% (3/51) of cats, positive urine culture in 22% 
(11/51) of cats, signs of dysuria in 22% (11/51) of cats and 2% (1/51) of cats had an anemia 
with a hematocrit of 16%.  
A second surgery had to be performed for replacement or reconditioning of the device in 10% 
(5/51) cats and for removal in 2% (1/51) cat. Four (8%) cats needed to replace the SUB due to 
the complete obstructions of the device while one cat (2%) had the distal extremity of the 
cystotomy catheter cut, due to a distal displacement of the catheter inside the urinary bladder. 
This resulted in chronic signs of dysuria and thickening of the urinary bladder’s wall (figure 24 
and 25). One (2%) cat had a nephrectomy performed because of advanced and severe kidney 
lesions associated with a chronic bacteriuria, therefore the SUB device was removed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One year and 6 months after the surgery, an abdominal ultrasound exam of one (2%) cat showed 
that its nephrostomy catheter was adhered to an intestinal loop, although flushing of the SUB 
device was not affected. Since a device occlusion was not presented, the owner decided to not 
remove the SUB device (figures 26 and 27). 
 
 
Legend: The cystotomy catheter is 2 cm inside the urinary bladder. The urinary bladder’s wall is 
thickening and irregular with 4 mm of thickness. 
 
Figure 24 and figure 25. Abdominal ultrasonographies showing a distal displacement of the 
cystotomy catheter (original, kindly provided by the CHV-Frégis).  
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Between 6 months and 1 year after the surgery, the mortality rate was 4% (2/51). In one (2%) 
of the cats a euthanasia was decided, since it had a severe renal insufficiency associated with a 
severe hyperkalemia, resulting from the obstruction of the device. This obstruction leaded also 
to the dilatation of the ipsilateral ureter with formation of an ampoule of 20 mm in the proximal 
portion of the ureter. 
4.6.3.4 Complications 2 years after SUB device placement 
For the 34 cats (36%) for which follow-up information was available, 26% (9/34) had an 
obstruction of the SUB device, 15% (5/34) had evidence of mineralization of the device, 29% 
(10/34) had an positive urine culture, 24% (8/34) demonstrated signs of dysuria and an anemia 
was presented in 6% (2/34, median value of hematocrit of 16.5%) of cats.  
A second surgery was performed in 2 (6%) cats, one for replacement of the SUB device and 
the other for its removal. In the latter case, the distal portion of the cystotomy catheter was 
completely adherent to a jejunal loop and even penetrated inside the loop, so the device had to 
be removed and a partial cystectomy and enterectomy were performed. In the meanwhile, the 
ureters of this cat showed signs of re-permeability, therefore, a second SUB device was not 
placed.  
One cat presented a cutaneous fistula at the level of the subcutaneous shunting port, with a 
purulent discharge, in which the bacteria Enterobacter cloacae was identified (the bacteria had 
already been identified in the urinary tract). 
Between 1 year and 2 years after the surgery, a mortality rate of approximately 3% (1) was 
identified, in which the cat was euthanized.   
Figure 26 and figure 27. Adherence of the nephrostomy catheter to an intestinal loop (original, 
kindly provided by CHV-Frégis). 
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4.6.3.5 Complications 3 years after SUB device placement 
Information about complications occurring 3 years after surgery was only available in 16 cats 
(12%). The most common complications detected were: occlusion of the SUB device system in 
31% (5/16) of cats, mineralization of the device in 13% (2/16) of cats, a positive urine culture 
in 25% (4/16) of cats, signs of dysuria in 13% (2/16) of cats and the presence of an anemia in 
1 cat (7%, value of the hematocrit 16.5%).  
In one cat, a second surgery was performed in order to remove the SUB device. A caudal 
displacement of the nephrostomy catheter resulted in a subscapular kidney abscess with 
engagement of the ipsilateral ureter, pancreas and duodenum in the abscess. Additionally, there 
was also an absence of permeability of the device whereas the ureters evidenced a recuperation 
of the permeability, hence the need to the device’s removal. 
Nearly 3 years after the surgery, in one cat, the abdominal ultrasound exam revealed an 
incarceration of the nephrostomy catheter in one intestinal loop. The ultrasound exam and the 
flush did not show signs of obstruction neither the animal had clinical signs of it, therefore the 
owners declined the recommendation from the clinicians to remove the device.   
There are records of one death, which conferred a mortality rate of 6%, between 2 and 3 years 
after the SUB placement. 
4.6.3.6 Complications 4 years after SUB device placement 
Only 4 cats had available information on complications, 4 years after the surgery. An occlusion 
of the SUB was found in one cat, but a flushing of the device restored the device’s permeability. 
Another cat had a positive urine culture along with signs of dysuria.  
In the table 1, the short and long-term complications are summarized.  
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4.7 Follow-up information 
Median serum creatinine concentrations at 1 week, 1 month, 3 months, 6 months, 1 year, 2 
years, 3 years and 4 years after surgery were 3 mg/ dL, 2.7 mg/dL, 2.4 mg/dL, 2.5 mg/dL, 2.4 
mg/dL, 2.6 mg/dL, 2.5 mg/dL and 2.7 mg/dL (figure X), respectively. 
Median urea creatinine concentrations at 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, 
3 years and 4 years after surgery were 110 mg/ dL, 83.7 mg/dL, 88.8 mg/dL, 86 mg/dL, 86 
mg/dL, 79.8 mg/dL, 87.9 mg/dL and 128 mg/dL (graph 1), respectively. 
Median renal pelvis diameter measured ultrasonographically in the transverse plane at 1 week, 
1 month, 3 months, 6 months, 1 year, 2 years and 3 years after surgery were 5.6mm, 3.8mm, 
5.4mm, 5.3mm, 4.1mm and 5mm, respectively. 
 
Time after 
surgery  
Obstruction Leakage Minerali
zation 
Dysuria Bacteriuria Anemia Mortality 
rate 
7 days (n=116) 10% 3% 0% 10% 9% 14% 14% 
1 month (n=61) 2% 2% 2% 18% 18% 7% 3% 
3 months (n=52) 8% 0% 0% 8% 13% 0% 2% 
6 months (n=49) 10% 2% 2% 16% 20% 2% 2% 
1 year (n=51) 20% 0% 6% 22% 22% 2% 4% 
2 years (n=34) 26% 15% 0% 24% 29% 6% 3% 
3 years (n=16) 31% 0% 13% 13% 25% 7% 6% 
4 years (n=4) 25% 0% 0% 25% 25% 0% 0% 
Overall (n=129) 32% 5% 8% 25% 19% 19% 19% 
Table 1. Summary of short and long-term complications of the SUB device placement. 
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Overall, complication rate, any time after the surgery, of cats that underwent a SUB device 
placement was: 5% (6) of cats had urine leakage, 8% (10) had mineralization of the SUB device, 
32% (41) had an occlusion of the device, 29% (38) presented signs of dysuria, in 25% (32) a 
positive urine culture was obtained and 19% (25) of cats were anemic. Therefore, 38% (49) of 
cats had major complications while 56% (72) of cats had minor complications. 
A second or more surgical interventions were needed for the replacement or reconditioning of 
the SUB device in 16 cats (12%). 
From the 129 cats, 24 (19%) died of a suspected renal or ureteral cause of death, any time after 
the surgery. 
A positive urine bacterial culture result was documented for 32 of 129 (25%) cats at some time 
after SUB device placement. Organisms isolated at any time after surgery consisted of 
Escherichia coli (13), Klebsiella pneumoniae (6), Enterobacter cloacae (6), Staphylococcus 
spp (5), Pseudomonas aeruginosa (4), Enterococcus spp (3) and other (6). The most common 
antibiotics employed were beta-lactams (16), fluoroquinolones (10), tetracyclines (6) and a 
combination of trimethoprim-sulfamethoxazole (6). Exceptionally, 8 cats (6%) did not receive 
antimicrobial treatment, either because the bacteria had a resistance profile or because a 
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Graph 1.Variation of the serum creatinine and urea concentrations through time. 
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subclinical bacteriuria was present. Neither of these cats presented any different clinical sign 
due to the cease of the antibiotic treatment. 
Results from the AST revealed that, any time after surgery, 10 cats had a positive urine culture 
with an antimicrobial resistance identified. From these, 2 cats had a low level of resistant 
bacteria, 2 cats had a medium level of resistant bacteria, 2 cats had a high level resistant bacteria  
and 4 cats had an initial medium level resistant bacteria identified and, in later urine culture, 
the same bacteria was identified with a low level resistance. Therefore, this happened also to 
another cat, in which an initial urine culture isolated a low level resistant bacteria and, multiple 
urine cultures latter, the same bacteria no longer presented a resistance profile. These 5 cats had 
an antibiotic treatment initially however, it did not solved the bacteriuria and, for this reason, 
clinicians decided to stop the antibiotic treatment. Several urine cultures after the interruption 
of the treatment, the bacteria revealed itself susceptible to more antibiotics and resistant to less 
antibiotics than before.  
The site of the SUB device obstruction was recorded for 19 cats in the nephrostomy catheter 
and for 12 cats in the cystotomy. Information about the cause of the obstruction was recorded 
for 10 cats: for 6 cats a blood clot caused the occlusion of the device, in 3 cats a mineralization 
of the device was the cause and for 1 cat, the cause was a urinary tract infection. A flush of the 
device was performed in order to solve the obstruction and information was available for 29 
cats: in 19 (66%) cats, the flush resolved the obstruction and in 10 (34%) cats, the obstruction 
did not resolved itself with the flush. 
 In 5 cats with occlusion of the device, a restoration of the permeability of the ureters was 
evidenced because of an absence of a pyelectasia, worsening of the azotemia and anuria or 
oliguria. From these, two cat had to remove its device, one because of a medium resistant 
bacteria associated with the device was presented and the other cat because the nephrostomy 
catheter was causing a subscapular kidney abscess. The other 3 cats kept their SUB devices. 
Information about the location of the mineralization of the SUB device was not always available 
but it was recorded that 9 cystotomy catheters and 5 nephrostomy catheters presented 
mineralization, any time after the surgery. 
4.8 Risk factor analysis 
The function of the probability of occurrence of a complication was obtained based in a Kaplan-
Meier curve, which reveals that 50% of cats had a first overall complication on a mean of 72 
days after the surgery, as presented in the graph 2.  
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However, when taking into account only major complications, 50% of cats presented a major 
complication on a mean of 541 days after the surgery, as presented in the graph 3. 
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Graph 2. Kaplan-Meier curve for cats with overall complications after the placement of 
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Graph 3. Kaplan-Meier curve for cats with major complications after the placement of 
the SUB device. 
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In the other hand, considering just minor complications, these were identified earlier in time, 
as demonstrated in the graph 4, in a mean of 148 days after the placement of the SUB device.  
 
 
 
 
 
 
 
 
 
 
The age of the cats was not significantly associated with complications (w = 1836.5, p = 0.8), 
regardless of being a major (w = 1749, p = 0.42) or minor complication (w = 2208, p = 0.3). 
Sex also did not had an influence in the occurrence of complications (χ2 (1) = 0.47, p = 0.5), 
major (χ2 (1) = 0.32, p = 0.57) or minor  (χ2 (1) = 0.05, p = 0.83), neither the reproductive 
status was associated with overall complications (χ2 (1) = 2.5, p = 0.11), major (χ2 (1) = 3.09, 
p = 0.07) or minor complications (χ2 (1) = 0.12, p = 0.73).  
The occurrence of a complication was significantly associated with anorexia or dysorexia (χ2 
(1) = 6.72, p = 0.009), in which a complication was identified in a mean of 24 days after the 
placement of the SUB versus 203 days for cats without anorexia or dysorexia at hospital 
admission. However, none of the following clinical signs at hospital admission had a 
significantly association with overall complications: signs of dysuria (χ2 (1) = 0.5, p = 0.48), 
weight loss (χ2 (1) = 1.11, p = 0.29), polyuria or polydipsia (χ2 (1) = 0.62, p = 0.43), vomiting 
(χ2 (1) = 0.38, p = 0.54), lethargy (χ2 (1) = 2.48, p = 0.12), oliguria or anuria (χ2 (1) = 1.13, p 
= 0.29) and abdominal pain (χ2 (1) = 0.1, p = 0.74). Hematuria was only presented in 4 cats 
preoperatively, therefore no statistics analysis were able to be performed.  
Graph 4. Kaplan-Meier curve for cats with minor complications after the placement of the 
SUB device. 
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Regarding major complications, lethargy at hospital admission (χ2 (1) = 3.92, p = 0.048) and 
oliguria or anuria (χ2 (1) = 7.16, p = 0.007) were significantly associated with the occurrence 
of a major complication. Cats presented with lethargy had a major complication identified in a 
mean of 430 days after the placement of the SUB versus 797 days for cats without lethargy and 
oliguric or anuric cats at the hospital admission presented a major complication a mean of 11 
days after the surgery versus 591 days for cats without oliguria or anuria. Other clinical signs 
were did not had an association: signs of dysuria (χ2 (1) = 0.12, p = 0.72), weight loss (χ2 (1) 
= 0.6, p = 0.44), polyuria or polydipsia (χ2 (1) = 0.04, p = 0.84), vomiting (χ2 (1) = 0.95, p = 
0.33), anorexia or dysorexia (χ2 (1) = 3.46, p = 0.06) and abdominal pain (χ2 (1) = 0.3, p = 
0.59).  
Concerning minor complications, a significant association was found with anorexia or 
dysorexia (χ2 (1) = 6.32, p = 0.01). A minor complication was identified 42 days versus 296 
days for cats who were not anorexic or dysorexic at the hospital admission. Other clinical signs 
did not had an association: signs of dysuria (χ2 (1) = 0.18, p = 0.67), weight loss (χ2 (1) = 1.66, 
p = 0.2), polyuria or polydipsia (χ2 (1) = 0.17, p = 0.68), vomiting (χ2 (1) = 0.04, p = 0.85), 
lethargy (χ2 (1) = 0.02, p = 0.89), oliguria or anuria (χ2 (1) = 0,73 p = 0.4) and abdominal pain 
(χ2 (1) = 0.62, p = 0.43).  
The serum concentration urea at hospital admission did not influence the development of 
complications (w = 1268.5, p = 0.88), major (w = 1495.5, p = 0.84) or minor (w = 1395, p = 
0.58) neither the serum concentration creatinine at the hospital admission influenced the 
occurrence of complications (w = 1365, p = 0.91), major (w = 1451, p = 0.74) or minor (w = 
1526, p = 0.92). Regarding serum potassium concentration disorders identified before the 
surgery, hyperkalemia was not significantly associated with complications (χ2 (1) = 0.004, p = 
0.95), (major (χ2 (1) = 0.05, p = 0.82) or minor (χ2 (1) = 0.12, p = 0.72). Since hypokalemia 
was only identified in 5 cats preoperatively, no static analysis were able to be performed.  
Preoperative anemia was not significantly associated with complications (χ2 (1) = 0.02, p = 
0.88), major (χ2 (1) = 0.32, p = 0.57) or minor (χ2 (1) = 1.06, p = 0.3). Preoperative urine 
specific gravity was not significantly associated with complications (w = 282.5, p = 0.75), major 
(w = 445.5, p = 0.23) or minor (w = 335.5, p = 0.58). 
Interestingly, a previous history of CKD was found to be significantly associated with minor 
complications (χ2 (1) = 0.29, p = 0.03). However, overall complications (χ2 (1) = 0.38, p = 
0.54) or major complications (χ2 (1) = 0.19, p = 0.66) did not had an association with a history 
of CKD. A history of other concomitants diseases was not significantly associated with the 
development of complications (χ2 (1) = 0.43, p = 0.51), major (χ2 (1) = 0.92, p = 0.37) or minor 
(χ2 (1) = 0.04, p = 0.84).  
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The placement of a bilateral SUB device was not significantly associated with complications 
(χ2 (1) = 1.1, p = 0.3), regardless of being major (χ2 (1) = 3.49, p = 0.06) or minor complications 
(χ2 (1) = 0.5, p = 0.48). 
The duration of the hospitalization was not significantly associated with the occurrence of 
complications (w = 1204, p = 0.42), regardless of being major (w = 1236.5, p = 0.68) or minor 
complications (w = 1205, p = 0.6).  
A weak positive correlation between the serum creatinine concentration at hospital admission 
and the hospitalization time (rho = 0.29, p = 0.005) likewise a weak positive correlation between 
the serum urea concentration at hospital admission and hospitalization time (rho = 0.28, p = 
0.007) were identified. As demonstrated in the graph 5, the duration of the hospitalization 
tended to increase with higher concentrations of serum creatinine and urea at hospital 
admission.  
The hospitalization time was significantly associated with oliguria or anuria at hospital 
admission (w = 189, p = 0.04) as well as with anorexia or dysorexia (w = 915.5, p = 0.04). 
Other clinical signs such as abdominal pain (w = 161, p = 0.15), hematuria (w = 270, p = 0.21), 
weight loss (w = 965, p = 0.52), vomiting (w = 1282, p = 0.94), lethargy (w = 1065, p = 0.08), 
polyuria and polydipsia (w = 701, p = 0.79) and signs of dysuria (w = 549, p=0.13) were not 
significantly associated with the days spent in the hospital. 
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Graph 5. Correlation between the serum creatinine and urea concentration at admission and 
hospitalization time. 
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The serum concentration urea at hospital discharge did not influence the development of 
complications (w = 944, p = 0.83), major (w = 1089, p = 0.89) or minor (w = 1042.5, p = 0.88) 
neither the serum concentration creatinine at the hospital admission influenced the occurrence 
of complications (w = 1004, p = 0.56), major (w = 1192.5, p = 0.62) or minor (w = 1112.5, p = 
0.8). 
The need for a second or more surgical interventions after the device placement was 
significantly associated with the occurrence of complications (χ2 (1) = 8.82, p = 0.003), major 
complications (χ2 (1) = 19.01, p < 0.001, or = 15.26) and minor (χ2 (1) = 4.8, p = 0.04, or = 
3.24). Therefore, cats submitted to further surgical interventions were 5 times more likely to 
develop major complications than minor ones. 
The development of signs of dysuria any time after the surgery was not significantly associated 
with preoperative signs of dysuria (x2 (1) = 1.04, p = 0.3). Neither episodes of anemia in the 
postoperative period was significantly associated with preoperative anemia (x2 (1) = 1.26, p = 
0.26).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
Interestingly, overall complications (x2 (1) = 0.008, p = 0.93), major complications (x2 (1) = 
0.003, p = 0.96) or minor complications (x2 (1) = 0.03, p = 0.86) were not significantly 
associated with death of cats with a suspected renal or ureteral cause. A survival curve 
demonstrated that 25% of cats died of suspected renal or ureteral cause a mean of 444 days after 
the SUB device placement (Graph 6). 
 
 
 
 
 
 
 
 
 
Graph 6. Kaplan-Meier survival curve of survival days of cats after the placement of the SUB 
device. 
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The death of cats with a suspected renal or ureteral cause was not significantly associated with 
the placement of a bilateral SUB device (x2 (1) = 0.42, p = 0.51), history of CKD (x2 (1) = 0.18, 
p = 0.67), other concomitant diseases (x2 (1) = 2.43, p = 0.12) or second or more surgeries after 
the SUB placement (x2 (1) = 0.02, p = 0.98). Moreover, any of the clinical signs registered at 
hospital admission were significantly associated with the mortality.  
Complications founded in these cats were not associated with the IRIS stage 1 month (w = 132, 
p = 0.68), 3 months (w = 207.5, p = 0.42), 6 months (w = 54.5, p = 0.27), 1 year (w = 103.5, p 
= 0.47), 2 years (w = 28, p = 0.05) and 3 years (w = 11, p = 0.91) after the surgery. Neither 
major or minor complications were also founded to be associated with the IRIS stage after the 
renal decompression.  
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5. DISCUSSION  
In this study, SUB devices were successfully placed in all cats, without fluoroscopic guidance, 
and only few cats experienced major postoperative complications. To the author’s knowledge, 
there is only two studies (Deroy et al., 2017; Livet et al., 2017) that described this procedure 
without fluoroscopy in the placement of a SUB device in 23 and 13 cats. Therefore, this study 
reinforces the success and safety of the implantation of the SUB device without the need of 
fluoroscopy. The surgeons are normally exposed to radiation when fluoroscopy is used and, 
since this equipment is not always accessible, this approach without fluoroscopy allows more 
surgeons to use SUB devices, with less individual and team risk. Despite that, there are some 
limitations associated that should be considered namely the complications that can come from 
the implant of the nephrostomy catheter in a minor pyelectasia or in the presence of nephroliths 
(Livet et al., 2017). In this present study, the implantation of the nephrostomy catheter had to 
be performed with ultrasound guidance (because fluoroscopy was not available) in one cat with 
a renal pelvic diameter of 3 mm, because the placement of the catheter presented difficulties 
during the surgery.   
The overall mortality rate was 19%, which is in agreement with previous published results 
(Deroy et al., 2017; Livet et al., 2017; Berent et al., 2018).  
Although the major cause of ureteral obstruction in the present study was ureterolithiasis, 
ureteral strictures and a recurrent cystitis by a ureteral stent also leaded to a SUB placement. 
Concurrently to the ureteral obstruction, nephroliths were also identified. Their presence could 
be a risk factor for reobstruction of the ureter since they have the potential to eventually pass 
into the ureter and obstruct it.  
After the diagnosis of ureterolithiasis, 61% of the cats in this study tried a medical treatment, 
in order to promote the spontaneously passage of the calculi, without reaching success in all of 
them. It is known that reported effective results of this therapy are very low and a risk of 
irreversible renal damage during medical management should not be ignored, stressing the 
individual need of judgement about the length of this option. Above all, the renal function 
should be preserved at any cost, since the probability of urolith’s recurrence in cats is high and, 
therefore, when attempting for the medical therapy, this should not be applied for more than 
72h (Kyles et al., 2005b; Lulich et al., 2016).   
Regarding intraoperative complications, these were rare and consisted on iatrogenic lesions in 
the kidney during the implantation, hemorrhage and urine leakage from the catheter. Despite 
that, no intraoperative deaths were identified. These complications had no major consequence, 
except for one of the cats who suffered from iatrogenic lesions with progressive degradation of 
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its clinical condition leading to a consented decision of euthanasia, 2 weeks later. Its clinical 
aggravation may have been a consequence of the combination of: intraoperative iatrogenic 
lesions, an important and prolonged preoperative degradation of its clinical condition and the 
presence of signs of CKD at the time of the diagnosis. In fact, more than the previous CKD, a 
prolonged anesthesia time could have influenced the renal which can get worse with possible 
intraoperative complications such as hypothermia and hypotension (Kulendra et al., 2014; Livet 
et al., 2017; Luca et al., 2017). In this case, the iatrogenic lesions during the surgery could have 
been related to the fact that the implantation of the nephrostomy catheter was performed without 
fluoroscopic guidance into a renal pelvis presenting a minor pyelectasia of only 3.8 mm. In the 
two previous studies in which fluoroscopy was not used, only one major intraoperative 
complication was reported, consisting in kinking of the nephrostomy catheter (Deroy et al., 
2017; Livet et al., 2017). This complication was not identified in the cats of this study.  
Concerning postoperative complications, a classification into major or minor was performed. 
This is mainly due to the fact that several complications such as dysuria or bacteriuria were 
typically temporary and resolved spontaneously or medically. Anemia was considered a minor 
complication. It may be a result of an underlying CKD, excessive blood sample or inflammation 
(Shipov & Segev, 2013; Livet et al., 2017). Nonetheless, anemia was not severe in any of those 
cases and was, therefore, not considered a major complication. Therefore, major complications 
associated with the SUB placement in the cats of this study were device occlusion (n=41, 32%), 
mineralization of the device (n=10, 8%) and urine leakage from the device or urinary tract (n=6, 
5%). These results are somewhat different from those previously reported. In this study, the 
occurrence of device occlusion is much higher compared with the reported (Deroy et al., 2017; 
Livet et al., 2017; Luca et al., 2017) but, in the other hand, kinking of the device was not founded 
in this study whereas in other studies this was identified in 5% of cases (Berent et al., 2018). 
The rate of urine leakage is approximately similar to the described in previous studies (Deroy 
et al., 2017; Luca et al., 2017) but mineralization of the SUB device was slightly higher in this 
study, compared to Deroy et al. (2017). Despite not very pronounced in this present study, urine 
leakage and kinking of a catheter typically occurred earlier after the surgery whereas 
mineralization of the device was almost always described in the long-term period (Berent et al., 
2018). 
Minor complications reported for cats in the present study were signs of dysuria in 29% (38) 
cats, a positive urine culture in 25% (32) of cats and an anemia in 19% (25) of cats. These 
values were consistent with the complication rate of previous studies (Deroy et al., 2017; Livet 
et al., 2017; Berent et al., 2018; Kopecny et al., 2019). Comparatively to ureteral stenting and 
traditional ureteral surgery, there are fewer complications associated with the placement of SUB 
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devices, when this is appropriately managed and monitored (Kyles et al., 2005b; Berent et al., 
2014; Kulendra et al., 2014; Culp et al., 2016; Wormser et al., 2016; Deroy et al., 2017). 
Current recommendations suggest that, flushing of the SUB device should be performed every 
3 to 4 months, in order to prevent a device obstruction (Berent & Weisse, 2018). With the 
advent of this recommendation, occlusions have been minimized (Berent, 2014).  The causes 
of the obstruction in cats of the present study were blood clots, mineralization and possible plug 
due to a urinary tract infection. Occlusion of the device secondary to a urinary infection was 
only been described before in one cat, by Vedrine (2017), in which the ureteral patency was 
restored with repetitive flushing of the device. In the cat of the present study, flushing of the 
device did not resolved the occlusion and the SUB device was removed. In previous studies, 
tissue plasminogen activator was reported to solved 36% of the occlusions due to a blood clot, 
resulting in a promising alternative to other invasive means of blood clot dissolution or 
extraction (Hoii & Lemetayer, 2017; Berent et al., 2018). Recently, infusion of tetra-EDTA 
solution for flushing of SUB devices has been employed to both prevent and treat urinary tract 
infections related with biofilm, as well as, the mineralization and occlusion of the SUB device 
(Berent & Weisse, 2018). As a matter of fact, Berent et al. (2018) observed a considerable 
decline in the mineralization rate since the used of this material routinely. However, since this 
is a recent material, flushing of the devices in the present study was performed with NaCl 0.9%. 
This may explain the higher rates of mineralization and occlusion founded. Despite the large 
number of occlusions, more than a half of them were resolved with flushing, demonstrating, 
once again, that the mechanical effect of the flush prevent and treat SUB obstructions.  
Several cats with occlusion of the device had the permeability of the native ureter restored. 
There is evidence of, once an ureterolithiasis is managed and the ureter is decompressed, a 
decreased in the luminal edema and hydrostatic pressure occurs and, in some cases, the passage 
of the ureterolith takes place (Berent et al., 2018). However, this may increase the risk for a 
urethral obstruction (Deroy et al., 2017; Livet et al., 2017).  
Some of the cats of this study presented complications associated with adherence or penetration 
of a catheter of the SUB device into an intestinal loop, in which half of the devices became 
obstructed and, consequently, had to be removed whereas, in the other half, the flushing of the 
device was not affected. To the author’s knowledge, these complications had not previously 
been reported in the literature and this is the first study that identify them in cats treated with a 
SUB device. Therefore, this study informs and alerts for unexpected complications that can 
cause occlusion of the device and can also lead to clinical digestives signs, which was the case 
for the two cats with the device occlusion, that manifested dysorexia and vomits.  
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Compared with the rates reported for ureteral stenting, this present study, together with other 
studies, demonstrated that cats with a SUB device developed lower rates of dysuria, which is 
likely a result of the location of the device. While the cystotomy catheter of the SUB is placed 
at the apex of the urinary bladder, the ureteral stent is historically positioned at the trigonal 
region and cranial to the portion of the urethra, inducing irritation of the urothelium (Berent et 
al., 2014; Deroy et al., 2017; Livet et al., 2017; Berent et al., 2018). Furthermore, when a 
ureteral stent was replaced by a SUB in cats presenting refractory signs of dysuria, an immediate 
resolution of the dysuria was noted (Deroy et al., 2017; Berent el al.,2018). Despite Berent et 
al. (2018) founded that the occurrence of dysuria after the placement of a SUB device was 
significantly associated with a previous existence of signs of dysuria before the surgery, this 
was not evidenced in the present study. Regardless of all of this, owners do not considered 
dysuria adversely affected the quality of life of their cats (Berent et al., 2018).  
Subclinical bacteriuria was reported in several cats in previous studies (Kopecny et al., 2019) 
and, according to the most recent guidelines from the ISCAID, the treatment of subclinical 
bacteriuria with antimicrobials, regardless of the resistance profile, is rarely indicated and 
discouraged. Moreover, anecdotal information suggests that, when the treatment is withheld, 
multidrug resistant organisms may, sometimes, be replaced with susceptible organisms (Weese 
et al., 2019). As a matter of fact, this was seen in some cats of this study, in which multiple 
urine cultures after the suspension of the treatment revealed an increase of susceptibility of the 
bacteria to antibiotics for which a resistance was recognized before. Therefore, this demonstrate 
that susceptible organisms may substitute multidrug resistant bacteria when not placed under 
an antimicrobial environment, at which treatment with routine antimicrobials may be more 
practical, if it becomes indicated (Weese et al., 2019). Although these results seem promising, 
further investigations are required to evaluate the response of multidrug resistance bacteria 
under different conditions.  
Typically, minor complications tended to occurred much earlier (148 days after the surgery) 
than major complications (541 days after surgery). However, minor complication were 
normally easily managed  and, for dysuria, its presence not seem to adversely affect the quality 
of life of cats, according to the owners opinion (Livet et al., 2017; Berent et al., 2018). 
 The only preoperative factor significantly associated with the occurrence of overall 
complications was the presence of anorexia or dysorexia before at hospital admission. These 
same clinical signs were also significantly associated with the occurrence of minor 
complications while major complications were significantly associated with lethargy and 
oliguria or anuria at the hospital admission. Despite most of these being no specific clinical 
signs, it may, in a way, help the clinician to anticipate certain complications.  
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Cats that had a known history of CKD before the ureteral obstruction episode were significantly 
associated only with the occurrence of minor complications. Cats with an advanced CKD may 
develop a uremic syndrome and anemia may be part of it (Shipov & Segev, 2013), so this may 
explain in part the association with minor complications. 
The need for a second or more surgical interventions after the device placement was 
significantly associated with the occurrence of complications and these cats were 5 times more 
likely to develop major complications than minor ones. This may be because minor 
complications usually do not need surgery for their resolution unlike some major complications 
such as urine leakage and unresolved device obstructions. Nevertheless, some cats with a 
chronic bacteriuria, which was probably associated with the SUB device biofilm, needed a 
device removal in order to clear that bacteriuria. Moreover, a second surgery was also needed 
for a cat with chronic dysuria, for reconditioning of the cystotomy catheter. Despite that, 
surgeries are more likely to be performed for the management of major complications.  
Interestingly, the mortality rate was not significantly associated neither with complications 
neither with other preoperative and postoperative parameters tested. This suggests that, 
predicting the patient outcome, prior and after the renal decompression, is difficult. 
The main limitation of the present study was its retrospective nature, which resulted in follow-
up parameters not perfectly homogeneous. A random selection of patients also did not occurred. 
Since this study included cats whom had SUB device placement until January 2019, in some 
cats, the follow-up period was too short to clearly establish long-term complications and 
outcome and, in particular, to compare. Some analysis and exams results were facilitated from 
the primary veterinary, therefore, different laboratories were involved, which may have affected 
result’s consistency. Since many drugs are not allowed in France, the antimicrobial susceptibly 
testing may also have been performed with lesser drugs than the usual in other countries, which 
may have affected the classification of bacteria. Despite that, the cohorts of cats in the present 
study represent the second largest regarding the placement of SUB devices for the treatment of 
feline ureteral obstruction in the veterinary literature. Furthermore, the placement of the SUB 
device was performed only by board-certified surgeons and surgical residents with their 
supervision, in order to improve the cat’s outcome.  
Several limitations are, however, recognised in this study. Indeed, it would had been interesting 
the implementation of questionnaire for the owners, for them to provide information about 
clinical signs and the quality of life of their cats. Moreover, the recurrent record of the 
concentrations of serum phosphorus and ionized calcium have been of major interest, because 
the medical records of cats presented in this study rarely had this information available and 
those are parameters that can be dramatically affected by a ureteral obstruction and a renal 
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disease. Also important would have been the study of crystalluria at the time of hospital 
admission. Also the medical treatment should have been better detailed in order to assess the 
potential relationship between the maximal delay of medical management until the SUB 
placement. Due to the retrospective nature of this study, this parameter could not be assessed. 
Concerning future perspectives, an interesting study for the future would be to investigate the 
effects of not treating a subclinical bacteriuria in cats that have a positive bacterial urine culture, 
(as recommend in the recent guidelines from ISCAID [Weese et al. (2019]), and to compare 
those effects to subclinical bacteriuria treated with antimicrobials. Another interesting 
investigation can eventually be the comparison between complications associated with SUB 
devices flushed with NaCl 0.9% versus those flushed with the tetra-EDTA solution.  
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6. CONCLUSION  
In the present study, SUB devices were introduced as palliative treatment for ureteral 
obstruction in cats, regardless of the cause and location of the obstruction. The surgical 
procedure was performed without fluoroscopic guidance, resulting in an effective and safe SUB 
placement, without revelant difficulties, demonstrating that fluoroscopy is not essential in all 
cases.  
Major complications described consisted mainly in device occlusion (n=41, 32%), 
mineralization of the device (n=10, 8%) and urine leakage from the device or urinary tract (n=6, 
5%). Likewise, minor complications were also founded: signs of dysuria in 29% (38) cats, a 
bacteriuria in 25% (32) of cats and an anemia in 19% (25) of cats. In contrast with previous 
studies (Berent et al., 2018), kinking of the device was not identified in the present study.  
Minor complications were observed a mean of 148 days after the surgery and were significantly 
associated with anorexia or dysorexia at the hospital admission and a history of CKD.  In the 
other hand, major complications were seen a mean of 541 days after the surgery and were 
associated with lethargy and oliguria or anuria at hospital admission.   
The overall mortality rate of the present study was 19% and, interestingly, cats who died of a 
suspected ureteral or renal causes were not associated with complications or other parameters 
tested, suggesting that, the prognosis of cats after the renal decompression remains uncertain.  
In summary, results of the present study suggest that SUB placement is a viable treatment of 
ureteral obstruction in cats, with fewer short and long-term complications when compared with 
ureteral stents or traditional ureteral surgery. Despite the difficulty to predict the patient 
outcome, prior and after to renal decompression, results of the present study show that cats with 
ureteral obstructions could have a good prognosis after a SUB device placement, when 
appropriately monitored. 
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